---
title: "Vitamin B12: Dosing & Vendor Prices — BodyHackGuide"
description: "Vitamin B12: dosing protocols, mechanism & side effects. Compare 1 verified vendor prices."
lang: en
json-ld: |
  [
    {
      "@context": "https://schema.org",
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.bodyhackguide.co/"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Compounds",
          "item": "https://www.bodyhackguide.co/compare"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Vitamin B12"
        }
      ]
    },
    {
      "@context": "https://schema.org",
      "@type": "Product",
      "name": "Vitamin B12",
      "description": "Vitamin B12 (cobalamin) is a water-soluble cobalt-containing vitamin that serves as a coenzyme for two critical enzymes in human metabolism: methionine synthase (cytoplasmic) and L-methylmalonyl-CoA mutase (mitochondrial). It is the largest and most structurally complex vitamin, built around a corrin ring that coordinates a central cobalt atom, with different upper-axial ligands defining the four commercially available forms — methylcobalamin, adenosylcobalamin, hydroxocobalamin, and cyanocobalamin. B12 is synthesized exclusively by bacteria and archaea; humans obtain it almost entirely from animal products (meat, fish, eggs, dairy) because plants do not produce or reliably retain bioactive cobalamin. This evolutionary dependency means that strict vegan and vegetarian diets predictably cause deficiency unless supplemented, and it means that any condition disrupting the remarkably complex absorptive pathway — atrophic gastritis, pernicious anemia, gastric bypass, ileal resection, metformin use, or proton pump inhibitor therapy — creates clinical deficiency even in people eating an omnivorous diet. Functionally, vitamin B12 sits at the intersection of methylation, DNA synthesis, hematopoiesis, myelin maintenance, and fatty acid metabolism. Methylcobalamin donates a methyl group to methionine synthase, which remethylates homocysteine to methionine and simultaneously converts 5-methyltetrahydrofolate back to tetrahydrofolate — a reaction that prevents the \"folate trap\" and keeps single-carbon units flowing through the folate cycle for purine, thymidylate, and methyl-donor synthesis. The methionine produced feeds S-adenosylmethionine (SAMe), the universal methyl donor used by dozens of methyltransferases that methylate DNA (affecting gene expression), histones (affecting chromatin state), neurotransmitters (epinephrine from norepinephrine via PNMT), myelin basic protein (affecting nerve sheath integrity), phospholipids (phosphatidylcholine via PEMT), and countless other substrates. Adenosylcobalamin serves L-methylmalonyl-CoA mutase inside mitochondria, catalyzing the isomerization of methylmalonyl-CoA to succinyl-CoA, which enters the citric acid cycle. Without adenosyl-B12, methylmalonic acid accumulates, disrupting odd-chain fatty acid metabolism and contributing to the neurological damage characteristic of B12 deficiency. Classical B12 deficiency produces a distinctive clinical picture that has been recognized for more than a century: megaloblastic anemia with large, immature red blood cells reflecting disrupted DNA synthesis in bone marrow; glossitis with a smooth, beefy-red tongue; gastrointestinal symptoms; and — most concerning — progressive neurological dysfunction known as subacute combined degeneration of the spinal cord. The neurological picture includes symmetric paresthesias (classically starting in the feet), impaired proprioception and vibratory sense, gait ataxia, weakness, optic neuropathy, and in advanced cases cognitive impairment, psychiatric symptoms, and frank dementia. The critical lesson from historical case series is that neurological damage can occur without anemia — and can become irreversible if deficiency is prolonged. Folic acid supplementation can mask the hematological changes while neurological deterioration continues, which is why high-dose folic acid in fortified foods and supplements has generated ongoing concern about missed B12 diagnoses in the elderly. For BodyHackGuide readers, the practical reality of B12 is that deficiency and insufficiency are far more common than most people realize. The classic at-risk groups — elderly with atrophic gastritis, vegans and long-term vegetarians, patients on metformin, patients on chronic PPIs, post-bariatric-surgery patients — together comprise a substantial fraction of adults. Serum B12 testing is insensitive and misses subclinical deficiency; methylmalonic acid (MMA) and homocysteine are more reliable functional markers, and holotranscobalamin (active B12) is superior where available. Oral supplementation at 500-1000 mcg/day is generally sufficient even for people lacking intrinsic factor, because passive diffusion absorbs roughly 1-2% of any oral dose regardless of the active receptor-mediated pathway. For active deficiency, parenteral hydroxocobalamin (1000 mcg IM weekly, then monthly) remains the standard and is genuinely life-changing for people with pernicious anemia or severe malabsorption. This page examines the cobalamin forms (and the overhyped claims around MTHFR and methyl-B12), absorption pathophysiology, testing, the homocysteine-lowering trials (VITACOG, VITATOPS, B-PROOF, VITAL), and practical dosing — with explicit attention to the elderly and vegan populations where B12 has the largest quality-of-life impact.",
      "url": "https://www.bodyhackguide.co/compound/vitamin-b12",
      "image": "https://www.bodyhackguide.co/og-image.png",
      "brand": {
        "@type": "Brand",
        "name": "Research Compound"
      },
      "offers": {
        "@type": "AggregateOffer",
        "lowPrice": "24.99",
        "highPrice": "24.99",
        "priceCurrency": "USD",
        "offerCount": "1",
        "availability": "https://schema.org/InStock",
        "offers": [
          {
            "@type": "Offer",
            "price": "24.99",
            "priceCurrency": "USD",
            "availability": "https://schema.org/InStock",
            "itemCondition": "https://schema.org/NewCondition",
            "url": "https://www.vandl-labs.com/product/vitamin-b-12/?ref=choncho",
            "seller": {
              "@type": "Organization",
              "name": "VANDL Labs",
              "url": "https://www.vandl-labs.com/?ref=choncho"
            }
          }
        ]
      }
    },
    {
      "@context": "https://schema.org",
      "@type": "MedicalWebPage",
      "name": "Vitamin B12",
      "description": "Vitamin B12 (cobalamin) is a water-soluble cobalt-containing vitamin that serves as a coenzyme for two critical enzymes in human metabolism: methionine synthase (cytoplasmic) and L-methylmalonyl-CoA mutase (mitochondrial). It is the largest and most structurally complex vitamin, built around a corrin ring that coordinates a central cobalt atom, with different upper-axial ligands defining the four commercially available forms — methylcobalamin, adenosylcobalamin, hydroxocobalamin, and cyanocobalamin. B12 is synthesized exclusively by bacteria and archaea; humans obtain it almost entirely from animal products (meat, fish, eggs, dairy) because plants do not produce or reliably retain bioactive cobalamin. This evolutionary dependency means that strict vegan and vegetarian diets predictably cause deficiency unless supplemented, and it means that any condition disrupting the remarkably complex absorptive pathway — atrophic gastritis, pernicious anemia, gastric bypass, ileal resection, metformin use, or proton pump inhibitor therapy — creates clinical deficiency even in people eating an omnivorous diet. Functionally, vitamin B12 sits at the intersection of methylation, DNA synthesis, hematopoiesis, myelin maintenance, and fatty acid metabolism. Methylcobalamin donates a methyl group to methionine synthase, which remethylates homocysteine to methionine and simultaneously converts 5-methyltetrahydrofolate back to tetrahydrofolate — a reaction that prevents the \"folate trap\" and keeps single-carbon units flowing through the folate cycle for purine, thymidylate, and methyl-donor synthesis. The methionine produced feeds S-adenosylmethionine (SAMe), the universal methyl donor used by dozens of methyltransferases that methylate DNA (affecting gene expression), histones (affecting chromatin state), neurotransmitters (epinephrine from norepinephrine via PNMT), myelin basic protein (affecting nerve sheath integrity), phospholipids (phosphatidylcholine via PEMT), and countless other substrates. Adenosylcobalamin serves L-methylmalonyl-CoA mutase inside mitochondria, catalyzing the isomerization of methylmalonyl-CoA to succinyl-CoA, which enters the citric acid cycle. Without adenosyl-B12, methylmalonic acid accumulates, disrupting odd-chain fatty acid metabolism and contributing to the neurological damage characteristic of B12 deficiency. Classical B12 deficiency produces a distinctive clinical picture that has been recognized for more than a century: megaloblastic anemia with large, immature red blood cells reflecting disrupted DNA synthesis in bone marrow; glossitis with a smooth, beefy-red tongue; gastrointestinal symptoms; and — most concerning — progressive neurological dysfunction known as subacute combined degeneration of the spinal cord. The neurological picture includes symmetric paresthesias (classically starting in the feet), impaired proprioception and vibratory sense, gait ataxia, weakness, optic neuropathy, and in advanced cases cognitive impairment, psychiatric symptoms, and frank dementia. The critical lesson from historical case series is that neurological damage can occur without anemia — and can become irreversible if deficiency is prolonged. Folic acid supplementation can mask the hematological changes while neurological deterioration continues, which is why high-dose folic acid in fortified foods and supplements has generated ongoing concern about missed B12 diagnoses in the elderly. For BodyHackGuide readers, the practical reality of B12 is that deficiency and insufficiency are far more common than most people realize. The classic at-risk groups — elderly with atrophic gastritis, vegans and long-term vegetarians, patients on metformin, patients on chronic PPIs, post-bariatric-surgery patients — together comprise a substantial fraction of adults. Serum B12 testing is insensitive and misses subclinical deficiency; methylmalonic acid (MMA) and homocysteine are more reliable functional markers, and holotranscobalamin (active B12) is superior where available. Oral supplementation at 500-1000 mcg/day is generally sufficient even for people lacking intrinsic factor, because passive diffusion absorbs roughly 1-2% of any oral dose regardless of the active receptor-mediated pathway. For active deficiency, parenteral hydroxocobalamin (1000 mcg IM weekly, then monthly) remains the standard and is genuinely life-changing for people with pernicious anemia or severe malabsorption. This page examines the cobalamin forms (and the overhyped claims around MTHFR and methyl-B12), absorption pathophysiology, testing, the homocysteine-lowering trials (VITACOG, VITATOPS, B-PROOF, VITAL), and practical dosing — with explicit attention to the elderly and vegan populations where B12 has the largest quality-of-life impact.",
      "lastReviewed": "2026-05-04T11:35:25.484+00:00",
      "url": "https://www.bodyhackguide.co/compound/vitamin-b12",
      "author": {
        "@type": "Person",
        "name": "BioChonch",
        "url": "https://www.bodyhackguide.co/about",
        "jobTitle": "Founder & Lead Researcher",
        "sameAs": [
          "https://x.com/bodyhackguide",
          "https://reddit.com/r/BodyHackGuide",
          "https://reddit.com/r/BrainHackGuide",
          "https://reddit.com/r/Biohackingher"
        ],
        "worksFor": {
          "@type": "Organization",
          "name": "BodyHackGuide",
          "url": "https://www.bodyhackguide.co"
        }
      },
      "reviewedBy": {
        "@type": "Person",
        "name": "BioChonch",
        "url": "https://www.bodyhackguide.co/about",
        "jobTitle": "Founder & Lead Researcher",
        "sameAs": [
          "https://x.com/bodyhackguide",
          "https://reddit.com/r/BodyHackGuide",
          "https://reddit.com/r/BrainHackGuide",
          "https://reddit.com/r/Biohackingher"
        ],
        "worksFor": {
          "@type": "Organization",
          "name": "BodyHackGuide",
          "url": "https://www.bodyhackguide.co"
        }
      },
      "publisher": {
        "@type": "Organization",
        "name": "BodyHackGuide",
        "url": "https://www.bodyhackguide.co"
      },
      "mainContentOfPage": {
        "@type": "WebPageElement",
        "cssSelector": "main"
      },
      "about": {
        "@type": "Drug",
        "name": "Vitamin B12",
        "alternateName": [
          "Cobalamin",
          "B12",
          "Methylcobalamin",
          "MeCbl",
          "Methyl-B12",
          "Hydroxocobalamin",
          "OHCbl",
          "Hydroxy-B12",
          "Cyanocobalamin",
          "CNCbl",
          "Adenosylcobalamin",
          "AdoCbl",
          "Dibencozide",
          "Coenzyme B12"
        ],
        "description": "Vitamin B12 (cobalamin) is a water-soluble cobalt-containing vitamin that serves as a coenzyme for two critical enzymes in human metabolism: methionine synthase (cytoplasmic) and L-methylmalonyl-CoA mutase (mitochondrial). It is the largest and most structurally complex vitamin, built around a corrin ring that coordinates a central cobalt atom, with different upper-axial ligands defining the four commercially available forms — methylcobalamin, adenosylcobalamin, hydroxocobalamin, and cyanocobalamin. B12 is synthesized exclusively by bacteria and archaea; humans obtain it almost entirely from animal products (meat, fish, eggs, dairy) because plants do not produce or reliably retain bioactive cobalamin. This evolutionary dependency means that strict vegan and vegetarian diets predictably cause deficiency unless supplemented, and it means that any condition disrupting the remarkably complex absorptive pathway — atrophic gastritis, pernicious anemia, gastric bypass, ileal resection, metformin use, or proton pump inhibitor therapy — creates clinical deficiency even in people eating an omnivorous diet. Functionally, vitamin B12 sits at the intersection of methylation, DNA synthesis, hematopoiesis, myelin maintenance, and fatty acid metabolism. Methylcobalamin donates a methyl group to methionine synthase, which remethylates homocysteine to methionine and simultaneously converts 5-methyltetrahydrofolate back to tetrahydrofolate — a reaction that prevents the \"folate trap\" and keeps single-carbon units flowing through the folate cycle for purine, thymidylate, and methyl-donor synthesis. The methionine produced feeds S-adenosylmethionine (SAMe), the universal methyl donor used by dozens of methyltransferases that methylate DNA (affecting gene expression), histones (affecting chromatin state), neurotransmitters (epinephrine from norepinephrine via PNMT), myelin basic protein (affecting nerve sheath integrity), phospholipids (phosphatidylcholine via PEMT), and countless other substrates. Adenosylcobalamin serves L-methylmalonyl-CoA mutase inside mitochondria, catalyzing the isomerization of methylmalonyl-CoA to succinyl-CoA, which enters the citric acid cycle. Without adenosyl-B12, methylmalonic acid accumulates, disrupting odd-chain fatty acid metabolism and contributing to the neurological damage characteristic of B12 deficiency. Classical B12 deficiency produces a distinctive clinical picture that has been recognized for more than a century: megaloblastic anemia with large, immature red blood cells reflecting disrupted DNA synthesis in bone marrow; glossitis with a smooth, beefy-red tongue; gastrointestinal symptoms; and — most concerning — progressive neurological dysfunction known as subacute combined degeneration of the spinal cord. The neurological picture includes symmetric paresthesias (classically starting in the feet), impaired proprioception and vibratory sense, gait ataxia, weakness, optic neuropathy, and in advanced cases cognitive impairment, psychiatric symptoms, and frank dementia. The critical lesson from historical case series is that neurological damage can occur without anemia — and can become irreversible if deficiency is prolonged. Folic acid supplementation can mask the hematological changes while neurological deterioration continues, which is why high-dose folic acid in fortified foods and supplements has generated ongoing concern about missed B12 diagnoses in the elderly. For BodyHackGuide readers, the practical reality of B12 is that deficiency and insufficiency are far more common than most people realize. The classic at-risk groups — elderly with atrophic gastritis, vegans and long-term vegetarians, patients on metformin, patients on chronic PPIs, post-bariatric-surgery patients — together comprise a substantial fraction of adults. Serum B12 testing is insensitive and misses subclinical deficiency; methylmalonic acid (MMA) and homocysteine are more reliable functional markers, and holotranscobalamin (active B12) is superior where available. Oral supplementation at 500-1000 mcg/day is generally sufficient even for people lacking intrinsic factor, because passive diffusion absorbs roughly 1-2% of any oral dose regardless of the active receptor-mediated pathway. For active deficiency, parenteral hydroxocobalamin (1000 mcg IM weekly, then monthly) remains the standard and is genuinely life-changing for people with pernicious anemia or severe malabsorption. This page examines the cobalamin forms (and the overhyped claims around MTHFR and methyl-B12), absorption pathophysiology, testing, the homocysteine-lowering trials (VITACOG, VITATOPS, B-PROOF, VITAL), and practical dosing — with explicit attention to the elderly and vegan populations where B12 has the largest quality-of-life impact.",
        "activeIngredient": "Vitamin B12",
        "mechanismOfAction": "Vitamin B12 exerts all of its biological effects through two cobalamin-dependent enzymes in human cells: cytoplasmic methionine synthase (MTR, using methylcobalamin) and mitochondrial L-methylmalonyl-CoA mutase (MUT, using 5'-deoxyadenosylcobalamin). Every clinical consequence of B12 deficiency — megaloblastic anemia, subacute combined degeneration of the spinal cord, elevated homocysteine, elevated methylmalonic acid, neuropsychiatric symptoms — traces back to dysfunction of one or both of these reactions. Understanding this molecular architecture is what makes B12 pharmacology coherent. METHIONINE SYNTHASE AND THE METHYL-B12 CYCLE. Methionine synthase catalyzes the transfer of a methyl group from 5-methyltetrahydrofolate (5-MTHF) to homocysteine, regenerating methionine and releasing tetrahydrofolate (THF). This single reaction accomplishes three critical things simultaneously. First, it clears homocysteine, a sulfur-containing amino acid that is cytotoxic at elevated concentrations and is associated with cardiovascular disease, cognitive decline, and neural tube defects. Second, it produces methionine, which is activated to S-adenosylmethionine (SAMe) — the universal methyl donor used by more than 100 known human methyltransferases to methylate DNA, RNA, histones, phospholipids (phosphatidylethanolamine → phosphatidylcholine via PEMT), neurotransmitters (norepinephrine → epinephrine via PNMT, serotonin synthesis via tryptophan hydroxylation), creatine, carnitine, myelin basic protein, and countless small molecules. Third, it regenerates free THF from 5-MTHF, which keeps one-carbon units flowing through the folate cycle toward purine and thymidylate synthesis — the \"folate trap\" concept describes what happens when B12 deficiency leaves folate stuck as 5-MTHF, unable to be recycled, which is why B12 deficiency produces hematological changes (megaloblastic anemia) indistinguishable from folate deficiency. The mechanism of methionine synthase is chemically striking: the cobalt atom of methylcobalamin cycles between the Co(I), Co(II), and Co(III) oxidation states during catalysis. The methyl group is transferred as a methyl cation, with methionine synthase reductase (MTRR) periodically reducing Co(II) back to Co(I) using S-adenosylmethionine as a methyl donor for maintenance. This complicated machinery is why methionine synthase function depends not only on B12 status but also on adequate flavin (MTRR uses FAD), folate (as 5-MTHF substrate), and appropriate MTRR activity — creating nutritional interconnections that real-world deficiency patterns reflect. METHYLMALONYL-COA MUTASE AND THE ADENOSYL-B12 CYCLE. In mitochondria, adenosylcobalamin supports L-methylmalonyl-CoA mutase, which catalyzes the rearrangement of L-methylmalonyl-CoA to succinyl-CoA. This reaction sits at the tail end of the catabolic pathway for propionyl-CoA, which is itself produced by the breakdown of odd-chain fatty acids, branched-chain amino acids (isoleucine, valine, methionine, threonine), cholesterol side chains, and thymine. Succinyl-CoA enters the citric acid cycle directly, providing energy and biosynthetic carbon. When adenosyl-B12 is deficient, methylmalonyl-CoA cannot be converted, leading to accumulation of methylmalonic acid (MMA) — the specific metabolite that serves as the gold-standard functional marker of B12 deficiency, with elevations detectable long before serum B12 falls below conventional cutoffs. MMA accumulation is thought to contribute to the neurological damage of B12 deficiency through several mechanisms: disruption of myelin synthesis (MMA is incorporated into abnormal odd-chain fatty acids that destabilize myelin membranes), mitochondrial dysfunction, and direct neurotoxicity at the high concentrations seen in inherited methylmalonic acidemias. The mechanism of methylmalonyl-CoA mutase involves radical chemistry: the Co-C bond of adenosylcobalamin homolytically cleaves to generate a 5'-deoxyadenosyl radical and Co(II), the radical abstracts a hydrogen from the substrate, carbon skeleton rearrangement occurs, and the hydrogen is returned to complete the isomerization. This is one of the few radical enzymatic mechanisms in human biology, and it is chemically impossible to accomplish without adenosylcobalamin — which is why no other vitamin can substitute for B12 in this function. ABSORPTION PATHWAY. The absorption of dietary B12 is extraordinarily complex and involves at least four binding proteins across multiple gastrointestinal compartments. Dietary B12 arrives protein-bound from animal food. In the stomach, acid and pepsin release B12 from food proteins, and salivary haptocorrin (R-binder) binds it with high affinity at low pH. In the proximal small intestine, pancreatic proteases digest haptocorrin at the now-alkaline pH, releasing B12, which is then transferred to intrinsic factor (IF) — a glycoprotein secreted by parietal cells in the gastric fundus. The B12-IF complex travels to the terminal ileum, where it binds to the cubilin-amnionless receptor complex (cubam) on enterocytes for receptor-mediated endocytosis. Inside the enterocyte, B12 is released from IF, bound to transcobalamin II (TC2), and exported to portal blood. In circulation, B12-TC2 (holotranscobalamin) is the functionally active form available for cellular uptake via the transcobalamin receptor. Total serum B12 is dominated by B12 bound to haptocorrin (which is not delivered to most tissues), which is why total serum B12 can be misleadingly normal in functional deficiency. This multi-step pathway creates multiple failure points: parietal cell destruction by autoimmune antibodies (pernicious anemia) eliminates intrinsic factor; atrophic gastritis with aging reduces acid and pepsin needed to release food-bound B12; Helicobacter pylori infection similarly impairs acid production; terminal ileal disease (Crohn's, resection, radiation enteritis) destroys the cubam receptor; metformin interferes with calcium-dependent IF-B12 binding to the cubam receptor; PPIs and H2 blockers reduce acid-mediated release from food (but do not affect synthetic supplemental B12 nearly as much); and fish tapeworm (Diphyllobothrium latum) competes for B12 in the lumen. Critically, passive diffusion across the intestinal mucosa absorbs roughly 1-2% of any oral dose regardless of IF — which means that pharmacologic oral dosing (1000-2000 mcg/day) can bypass most absorptive defects and achieve adequate repletion in most patients with pernicious anemia, a finding validated in controlled trials (PMID 15671234). FORM SELECTION. Four cobalamin forms are commercially available: methylcobalamin (methyl-B12), adenosylcobalamin (dibencozide, coenzyme B12), hydroxocobalamin (OH-B12), and cyanocobalamin. The methyl and adenosyl forms are the biologically active coenzymes used directly by the two human enzymes. Hydroxocobalamin is converted intracellularly to both active forms and is the preferred parenteral form in most of the world (it has a longer half-life than cyanocobalamin, binds tissue proteins more avidly, and is retained better, allowing less frequent dosing). Cyanocobalamin is the most stable and cheapest form; it must be intracellularly converted by cyanocobalamin reductase to the active forms, releasing trace cyanide (about 20 mcg per 1000 mcg dose, a dose 50-fold below toxic thresholds and inconsequential in anyone except the severely malnourished or those with tobacco amblyopia or Leber's hereditary optic neuropathy, where hydroxocobalamin is preferred because it can actively bind and detoxify cyanide). For oral and sublingual supplementation, the practical difference between forms is small for most users: all are converted to the active coenzymes intracellularly, and serum B12 response is comparable. The strong marketing preference for methyl-B12 (particularly among biohackers citing MTHFR polymorphisms) is not well-supported by comparative pharmacokinetic data — cyanocobalamin, methylcobalamin, and hydroxocobalamin all restore serum B12, MMA, and homocysteine to normal with appropriate dosing, and MTHFR polymorphisms affect folate metabolism, not B12 utilization. The one scenario where the form does clearly matter is severe, acute deficiency with neurological manifestations, where parenteral hydroxocobalamin achieves faster tissue repletion than oral dosing and may produce more rapid neurological recovery. Chronic maintenance of repletion is essentially form-agnostic at adequate doses. HOMOCYSTEINE AND METHYLATION CROSS-TALK. Elevated homocysteine (hyperhomocysteinemia) is the biochemical signature of combined B12, folate, and B6 deficiency, with B12 being the most common single cause in adults. Homocysteine is metabolized by two pathways: remethylation to methionine (via methionine synthase with B12/folate, or via betaine-homocysteine methyltransferase in liver using choline-derived betaine) and transsulfuration to cystathionine and then cysteine (via cystathionine β-synthase with vitamin B6). Deficient B12 impairs remethylation, elevating homocysteine and disrupting the methionine/SAMe cycle. The downstream effects include reduced SAMe-dependent methylation of DNA (potential epigenetic dysregulation), neurotransmitters (affecting mood and cognition), phospholipids (affecting membrane and myelin integrity), and the catalytic cycle of methionine synthase itself. High homocysteine is independently associated with cardiovascular disease, stroke, dementia, osteoporotic fracture, and (in early pregnancy) neural tube defects, though the trials aimed at improving these outcomes with B-vitamin supplementation have yielded mixed results.",
        "dosageForm": "vial",
        "legalStatus": "Not approved for human use — research chemical",
        "warning": "For research purposes only. Not for human consumption."
      }
    },
    {
      "@context": "https://schema.org",
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "What''s the difference between methylcobalamin and cyanocobalamin? Does it actually matter which one I take?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Methylcobalamin is a biologically active coenzyme form used directly by methionine synthase; cyanocobalamin is a stable synthetic form that must be intracellularly converted (releasing about 20 mcg of cyanide per 1000 mcg dose, which is far below any toxic threshold in normal users). For most healthy people taking oral maintenance doses, the practical difference is minimal — both correct deficiency, both normalize MMA and homocysteine, and serum B12 response is comparable (PMID 23356638). The strong marketing preference for methylcobalamin is not supported by head-to-head pharmacokinetic data in healthy users. Methylcobalamin is genuinely preferred in specific populations: Leber''s hereditary optic neuropathy, tobacco amblyopia, and users with documented conversion defects. Hydroxocobalamin is actually the best parenteral form globally (longer half-life, cyanide-binding properties), and is preferred for injections. If you feel subjectively better on methylcobalamin or have one of the specific clinical indications, use it. If cost matters and you''re otherwise healthy, cyanocobalamin is entirely adequate."
          }
        },
        {
          "@type": "Question",
          "name": "I''m on metformin — do I really need to supplement B12?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Yes, probably. The Diabetes Prevention Program Outcomes Study (PMID 26764326) demonstrated that long-term metformin (≥4 years) approximately doubles the rate of biochemical B12 deficiency (4.3% vs 2.3% on placebo), and smaller studies show metformin reduces B12 absorption by 20-30% through interference with calcium-dependent intrinsic-factor-mediated uptake in the terminal ileum. Multiple consensus guidelines now recommend periodic B12 screening in patients on chronic metformin. The practical recommendation is straightforward: if you''ve been on metformin for more than 2-4 years, take 500-1000 mcg oral B12 daily (any form is adequate), and check serum B12 plus MMA every 1-2 years. You don''t need to stop metformin — high-dose oral supplementation overcomes the absorption interference. Calcium 500-1200 mg/day has been shown to partially reverse metformin''s B12 effect (PMID 16567804), but most users don''t need specific calcium supplementation for this reason."
          }
        },
        {
          "@type": "Question",
          "name": "I''m vegan (or vegetarian) — what dose of B12 do I actually need?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Vegans are functionally guaranteed to develop B12 deficiency without supplementation — Pawlak''s meta-analysis (PMID 23356638) found 52% of vegans are deficient vs <3% of omnivores. The minimum effective supplemental dose for vegans is 500-1000 mcg oral B12 daily (any form). Long-term vegans who have been supplementing adequately and have documented normal B12, MMA, and homocysteine can step down to 1000 mcg twice weekly or 2000 mcg weekly (higher dose less frequently exploits the passive-diffusion mechanism and is adequate for maintenance). Lacto-ovo-vegetarians can often maintain with 100-500 mcg daily plus dairy and egg intake, though supplementation is still recommended for insurance. Spirulina, nori, tempeh, and fermented foods contain B12 analogs that are NOT reliably bioactive in humans — do not depend on these as your B12 source. Fortified plant milks and nutritional yeast (if fortified) can provide some B12 but are not reliable substitutes for supplementation. Pregnant vegans absolutely must supplement 500-1000 mcg daily; infants of unsupplemented vegan mothers develop severe neurological damage that may be irreversible."
          }
        },
        {
          "@type": "Question",
          "name": "How do I know if I''m actually B12 deficient? My serum B12 was normal but I feel tired and foggy.",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Serum B12 is an insensitive marker that misses a substantial fraction of functional deficiency. The more sensitive tests are methylmalonic acid (MMA) and total homocysteine — MMA above 270-400 nmol/L or homocysteine above 10-12 μmol/L suggests B12 insufficiency even with normal serum B12. Holotranscobalamin (the active B12 fraction) is the most sensitive marker where available (PMID 20978274). If you have symptoms consistent with B12 deficiency (fatigue, cognitive fog, paresthesias, mood changes, glossitis) and normal serum B12, ask for MMA and homocysteine testing. A therapeutic trial is also reasonable: take 1000 mcg methylcobalamin daily for 6-8 weeks and track symptoms. Most deficient users notice improvement within 2-4 weeks. Be aware that folic acid supplementation (from fortified foods or prenatal vitamins) can correct the macrocytic anemia of B12 deficiency while masking it, which is why testing MMA and homocysteine is important rather than relying on complete blood count alone."
          }
        },
        {
          "@type": "Question",
          "name": "Do I need B12 injections, or are pills good enough?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Oral B12 at adequate doses (1000-2000 mcg/day) is equivalent to intramuscular injections for most patients, including those with pernicious anemia (PMID 9694707). This is because passive diffusion across the intestinal mucosa absorbs approximately 1-2% of any oral dose regardless of intrinsic factor status, so a 2000 mcg oral dose delivers 20-40 mcg systemically — well above daily requirements. Injections are genuinely preferred in a few scenarios: severe acute neurological symptoms where rapid tissue repletion matters; patients with very severe malabsorption from extensive ileal resection or radiation enteritis; patients with poor medication adherence; and situations where insurance/access makes monthly IM more convenient than daily oral. Many patients with pernicious anemia do well on either approach and can switch based on preference, provided they verify continued normal MMA and homocysteine on whatever regimen they choose. The bias toward injections for pernicious anemia is partially historical — B12 pills weren''t available at adequate doses when pernicious anemia treatment protocols were established."
          }
        },
        {
          "@type": "Question",
          "name": "My homocysteine is elevated. Does B12 actually help?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Yes — B12, folate, and B6 reliably lower homocysteine by 25-30%, with B12 typically the dominant contributor in deficient older adults. However, the clinical significance depends on what you''re trying to achieve. For preventing cardiovascular events, the large homocysteine-lowering trials (HOPE-2, VISP, VITATOPS) have largely failed to show benefit in folate-replete populations — lowering homocysteine does not, on current evidence, reduce heart attack or cardiovascular death (PMID 28816361). For cognitive benefit, the VITACOG trial (PMID 20838622) showed a 30% reduction in brain atrophy and improved cognitive function in elderly patients with mild cognitive impairment and elevated homocysteine treated with high-dose B12/folate/B6 for two years. The practical synthesis: if your homocysteine is elevated, identify and correct the underlying B-vitamin deficiency (usually B12 or folate); the biochemical improvement is almost universal; the clinical benefit is strongest for early cognitive decline in deficient elderly, modest for stroke prevention, and essentially absent for heart attack prevention in already folate-replete populations. Standard dosing is B12 500-1000 mcg + folate 400-800 mcg + B6 10-25 mg daily."
          }
        },
        {
          "@type": "Question",
          "name": "Can I take too much B12?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Practically, no. The Institute of Medicine has not established an upper limit because no meaningful toxicity has been observed even at very high intakes. Doses of 10,000 mcg daily (50x the RDA) have been used in trials without adverse events. Excess B12 is cleared in urine and does not accumulate to dangerous levels. There are a few caveats: high-dose B12 (particularly injections) can precipitate or worsen acne in some users (PMID 25720358); very high doses can mask folate deficiency diagnostically if folate is also inadequate; and observational data have raised weak, inconsistent signals about potential cancer associations at extreme doses, which are not established as causal. For healthy users, doses above 2000 mcg/day offer no additional benefit over 1000-2000 mcg and are mostly a waste of money. Staying in the 500-2000 mcg daily range is safe, effective, and economical for nearly all purposes."
          }
        },
        {
          "@type": "Question",
          "name": "Will B12 give me energy if I''m not deficient?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Probably not in any meaningful way. The common belief that B12 is an ''energy vitamin'' and B12 injections boost stamina in non-deficient users is largely a placebo effect. Controlled trials of B12 in non-deficient subjects consistently show no benefit on fatigue, exercise performance, or subjective energy. The apparent energy boost from B12 injections reported by some users likely reflects a combination of placebo, demand characteristics, and perhaps vitamin-injection ritual effects, rather than any physiological improvement. The scenario where B12 dramatically improves energy is correction of actual deficiency — users with low MMA/homocysteine/holotranscobalamin or symptomatic deficiency commonly describe major fatigue and cognitive improvement within 2-6 weeks of starting therapy. If you''re a healthy, well-nourished person with normal B12 status and you''re tired, B12 injections are not the answer; investigate sleep, exercise, thyroid, iron, depression, and other common causes of fatigue before concluding that B12 will help."
          }
        },
        {
          "@type": "Question",
          "name": "What about MTHFR mutations? Do I need methyl-B12 specifically?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Almost certainly not, despite extensive marketing to this effect. MTHFR polymorphisms (particularly C677T and A1298C) affect the folate cycle by reducing methylenetetrahydrofolate reductase activity, which produces modest accumulation of homocysteine and modest reduction of 5-methyltetrahydrofolate. These polymorphisms do not directly affect B12 metabolism, and there is no compelling evidence that people with MTHFR variants require methylcobalamin specifically rather than cyanocobalamin or hydroxocobalamin. MTHFR variants may modestly favor methylfolate (L-5-MTHF) over folic acid supplementation for folate repletion, but the B12 form choice is largely independent. The ''methyl-B12 for MTHFR'' recommendation is a marketing-driven pseudo-medicalization of a very common polymorphism (the heterozygous C677T occurs in 30-40% of the population) that has modest, inconsistent clinical significance. If you have MTHFR and elevated homocysteine, 500-1000 mcg of any form of B12 plus 400-800 mcg methylfolate or folic acid daily is appropriate and well-supported. If you subjectively prefer methyl-B12, there''s no harm in using it, but don''t pay a large premium for it based on MTHFR testing alone."
          }
        },
        {
          "@type": "Question",
          "name": "Is it safe to take B12 long-term? Forever?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Yes, for the overwhelming majority of users. B12 has been used as daily maintenance supplementation in pernicious anemia patients for more than 70 years, and long-term daily high-dose therapy (500-2000 mcg/day) has one of the best safety records of any supplement in clinical use. No tolerance develops, no accumulation toxicity occurs, and stopping therapy after long-term use produces no rebound phenomena. The rare issues to monitor are: acneiform skin reactions (reduce dose or switch form if they appear); allergic reactions (rare but require form changes or discontinuation); and the ongoing background concern about very-high-dose B-vitamin supplementation and cancer in specific populations (weakly supported, not a reason to avoid normal dosing). The adult over 50 population has the strongest indication for indefinite B12 supplementation given the progressive decline in food-bound B12 absorption with aging atrophic gastritis; starting 500-1000 mcg daily in your 50s and continuing indefinitely is a reasonable default. Periodic MMA and homocysteine checks every 2-5 years confirm continued adequacy; serum B12 will be elevated on supplementation and is not a useful tracking marker."
          }
        }
      ]
    },
    {
      "@context": "https://schema.org",
      "@type": "Organization",
      "@id": "https://www.bodyhackguide.co#organization",
      "name": "BodyHackGuide",
      "alternateName": "BHG",
      "url": "https://www.bodyhackguide.co",
      "logo": {
        "@type": "ImageObject",
        "url": "https://www.bodyhackguide.co/logo.png",
        "width": 512,
        "height": 512
      },
      "description": "Evidence-based research reference for peptides and nootropics. 124+ compound profiles, interactive dosing calculators, real-time vendor pricing, and trust-scored vendor reviews scored on a public, reproducible methodology applied to every vendor. BodyHackGuide and BHG Labs share common ownership, and we earn a commission on purchases through our links.",
      "foundingDate": "2024",
      "founder": {
        "@id": "https://www.bodyhackguide.co/about#person"
      },
      "sameAs": [
        "https://x.com/bodyhackguide",
        "https://reddit.com/r/BodyHackGuide",
        "https://reddit.com/r/BrainHackGuide",
        "https://reddit.com/r/Biohackingher",
        "https://discord.gg/Mhq5UdRYBA"
      ],
      "knowsAbout": [
        "Peptide research",
        "Nootropic research",
        "Biohacking",
        "Compound dosing",
        "Vendor transparency"
      ],
      "publishingPrinciples": "https://www.bodyhackguide.co/editorial-standards",
      "ethicsPolicy": "https://www.bodyhackguide.co/editorial-standards",
      "diversityPolicy": "https://www.bodyhackguide.co/editorial-standards"
    },
    {
      "@context": "https://schema.org",
      "@type": "Product",
      "name": "Vitamin B12",
      "description": "Vitamin B12 (cobalamin) is a water-soluble cobalt-containing vitamin that serves as a coenzyme for two critical enzymes in human metabolism: methionine synthase (cytoplasmic) and L-methylmalonyl-CoA mutase (mitochondrial). It is the largest and most structurally complex vitamin, built around a corrin ring that coordinates a central cobalt atom, with different upper-axial ligands defining the four commercially available forms — methylcobalamin, adenosylcobalamin, hydroxocobalamin, and cyanocobalamin. B12 is synthesized exclusively by bacteria and archaea; humans obtain it almost entirely from animal products (meat, fish, eggs, dairy) because plants do not produce or reliably retain bioactive cobalamin. This evolutionary dependency means that strict vegan and vegetarian diets predictably cause deficiency unless supplemented, and it means that any condition disrupting the remarkably complex absorptive pathway — atrophic gastritis, pernicious anemia, gastric bypass, ileal resection, metformin use, or proton pump inhibitor therapy — creates clinical deficiency even in people eating an omnivorous diet. Functionally, vitamin B12 sits at the intersection of methylation, DNA synthesis, hematopoiesis, myelin maintenance, and fatty acid metabolism. Methylcobalamin donates a methyl group to methionine synthase, which remethylates homocysteine to methionine and simultaneously converts 5-methyltetrahydrofolate back to tetrahydrofolate — a reaction that prevents the \"folate trap\" and keeps single-carbon units flowing through the folate cycle for purine, thymidylate, and methyl-donor synthesis. The methionine produced feeds S-adenosylmethionine (SAMe), the universal methyl donor used by dozens of methyltransferases that methylate DNA (affecting gene expression), histones (affecting chromatin state), neurotransmitters (epinephrine from norepinephrine via PNMT), myelin basic protein (affecting nerve sheath integrity), phospholipids (phosphatidylcholine via PEMT), and countless other substrates. Adenosylcobalamin serves L-methylmalonyl-CoA mutase inside mitochondria, catalyzing the isomerization of methylmalonyl-CoA to succinyl-CoA, which enters the citric acid cycle. Without adenosyl-B12, methylmalonic acid accumulates, disrupting odd-chain fatty acid metabolism and contributing to the neurological damage characteristic of B12 deficiency. Classical B12 deficiency produces a distinctive clinical picture that has been recognized for more than a century: megaloblastic anemia with large, immature red blood cells reflecting disrupted DNA synthesis in bone marrow; glossitis with a smooth, beefy-red tongue; gastrointestinal symptoms; and — most concerning — progressive neurological dysfunction known as subacute combined degeneration of the spinal cord. The neurological picture includes symmetric paresthesias (classically starting in the feet), impaired proprioception and vibratory sense, gait ataxia, weakness, optic neuropathy, and in advanced cases cognitive impairment, psychiatric symptoms, and frank dementia. The critical lesson from historical case series is that neurological damage can occur without anemia — and can become irreversible if deficiency is prolonged. Folic acid supplementation can mask the hematological changes while neurological deterioration continues, which is why high-dose folic acid in fortified foods and supplements has generated ongoing concern about missed B12 diagnoses in the elderly. For BodyHackGuide readers, the practical reality of B12 is that deficiency and insufficiency are far more common than most people realize. The classic at-risk groups — elderly with atrophic gastritis, vegans and long-term vegetarians, patients on metformin, patients on chronic PPIs, post-bariatric-surgery patients — together comprise a substantial fraction of adults. Serum B12 testing is insensitive and misses subclinical deficiency; methylmalonic acid (MMA) and homocysteine are more reliable functional markers, and holotranscobalamin (active B12) is superior where available. Oral supplementation at 500-1000 mcg/day is generally sufficient even for people lacking intrinsic factor, because passive diffusion absorbs roughly 1-2% of any oral dose regardless of the active receptor-mediated pathway. For active deficiency, parenteral hydroxocobalamin (1000 mcg IM weekly, then monthly) remains the standard and is genuinely life-changing for people with pernicious anemia or severe malabsorption. This page examines the cobalamin forms (and the overhyped claims around MTHFR and methyl-B12), absorption pathophysiology, testing, the homocysteine-lowering trials (VITACOG, VITATOPS, B-PROOF, VITAL), and practical dosing — with explicit attention to the elderly and vegan populations where B12 has the largest quality-of-life impact.",
      "url": "https://www.bodyhackguide.co/compound/vitamin-b12",
      "image": "https://www.bodyhackguide.co/og-image.png",
      "brand": {
        "@type": "Brand",
        "name": "Research Compound"
      },
      "offers": {
        "@type": "AggregateOffer",
        "lowPrice": "24.99",
        "highPrice": "24.99",
        "priceCurrency": "USD",
        "offerCount": "1",
        "availability": "https://schema.org/InStock",
        "offers": [
          {
            "@type": "Offer",
            "price": "24.99",
            "priceCurrency": "USD",
            "availability": "https://schema.org/InStock",
            "itemCondition": "https://schema.org/NewCondition",
            "url": "https://www.vandl-labs.com/product/vitamin-b-12/?ref=choncho",
            "seller": {
              "@type": "Organization",
              "name": "VANDL Labs",
              "url": "https://www.vandl-labs.com/?ref=choncho"
            }
          }
        ]
      }
    },
    {
      "@context": "https://schema.org",
      "@type": "MedicalWebPage",
      "name": "Vitamin B12",
      "description": "Vitamin B12 (cobalamin) is a water-soluble cobalt-containing vitamin that serves as a coenzyme for two critical enzymes in human metabolism: methionine synthase (cytoplasmic) and L-methylmalonyl-CoA mutase (mitochondrial). It is the largest and most structurally complex vitamin, built around a corrin ring that coordinates a central cobalt atom, with different upper-axial ligands defining the four commercially available forms — methylcobalamin, adenosylcobalamin, hydroxocobalamin, and cyanocobalamin. B12 is synthesized exclusively by bacteria and archaea; humans obtain it almost entirely from animal products (meat, fish, eggs, dairy) because plants do not produce or reliably retain bioactive cobalamin. This evolutionary dependency means that strict vegan and vegetarian diets predictably cause deficiency unless supplemented, and it means that any condition disrupting the remarkably complex absorptive pathway — atrophic gastritis, pernicious anemia, gastric bypass, ileal resection, metformin use, or proton pump inhibitor therapy — creates clinical deficiency even in people eating an omnivorous diet. Functionally, vitamin B12 sits at the intersection of methylation, DNA synthesis, hematopoiesis, myelin maintenance, and fatty acid metabolism. Methylcobalamin donates a methyl group to methionine synthase, which remethylates homocysteine to methionine and simultaneously converts 5-methyltetrahydrofolate back to tetrahydrofolate — a reaction that prevents the \"folate trap\" and keeps single-carbon units flowing through the folate cycle for purine, thymidylate, and methyl-donor synthesis. The methionine produced feeds S-adenosylmethionine (SAMe), the universal methyl donor used by dozens of methyltransferases that methylate DNA (affecting gene expression), histones (affecting chromatin state), neurotransmitters (epinephrine from norepinephrine via PNMT), myelin basic protein (affecting nerve sheath integrity), phospholipids (phosphatidylcholine via PEMT), and countless other substrates. Adenosylcobalamin serves L-methylmalonyl-CoA mutase inside mitochondria, catalyzing the isomerization of methylmalonyl-CoA to succinyl-CoA, which enters the citric acid cycle. Without adenosyl-B12, methylmalonic acid accumulates, disrupting odd-chain fatty acid metabolism and contributing to the neurological damage characteristic of B12 deficiency. Classical B12 deficiency produces a distinctive clinical picture that has been recognized for more than a century: megaloblastic anemia with large, immature red blood cells reflecting disrupted DNA synthesis in bone marrow; glossitis with a smooth, beefy-red tongue; gastrointestinal symptoms; and — most concerning — progressive neurological dysfunction known as subacute combined degeneration of the spinal cord. The neurological picture includes symmetric paresthesias (classically starting in the feet), impaired proprioception and vibratory sense, gait ataxia, weakness, optic neuropathy, and in advanced cases cognitive impairment, psychiatric symptoms, and frank dementia. The critical lesson from historical case series is that neurological damage can occur without anemia — and can become irreversible if deficiency is prolonged. Folic acid supplementation can mask the hematological changes while neurological deterioration continues, which is why high-dose folic acid in fortified foods and supplements has generated ongoing concern about missed B12 diagnoses in the elderly. For BodyHackGuide readers, the practical reality of B12 is that deficiency and insufficiency are far more common than most people realize. The classic at-risk groups — elderly with atrophic gastritis, vegans and long-term vegetarians, patients on metformin, patients on chronic PPIs, post-bariatric-surgery patients — together comprise a substantial fraction of adults. Serum B12 testing is insensitive and misses subclinical deficiency; methylmalonic acid (MMA) and homocysteine are more reliable functional markers, and holotranscobalamin (active B12) is superior where available. Oral supplementation at 500-1000 mcg/day is generally sufficient even for people lacking intrinsic factor, because passive diffusion absorbs roughly 1-2% of any oral dose regardless of the active receptor-mediated pathway. For active deficiency, parenteral hydroxocobalamin (1000 mcg IM weekly, then monthly) remains the standard and is genuinely life-changing for people with pernicious anemia or severe malabsorption. This page examines the cobalamin forms (and the overhyped claims around MTHFR and methyl-B12), absorption pathophysiology, testing, the homocysteine-lowering trials (VITACOG, VITATOPS, B-PROOF, VITAL), and practical dosing — with explicit attention to the elderly and vegan populations where B12 has the largest quality-of-life impact.",
      "lastReviewed": "2026-05-04T11:35:25.484+00:00",
      "url": "https://www.bodyhackguide.co/compound/vitamin-b12",
      "author": {
        "@type": "Person",
        "name": "BioChonch",
        "url": "https://www.bodyhackguide.co/about",
        "jobTitle": "Founder & Lead Researcher",
        "sameAs": [
          "https://x.com/bodyhackguide",
          "https://reddit.com/r/BodyHackGuide",
          "https://reddit.com/r/BrainHackGuide",
          "https://reddit.com/r/Biohackingher"
        ],
        "worksFor": {
          "@type": "Organization",
          "name": "BodyHackGuide",
          "url": "https://www.bodyhackguide.co"
        }
      },
      "reviewedBy": {
        "@type": "Person",
        "name": "BioChonch",
        "url": "https://www.bodyhackguide.co/about",
        "jobTitle": "Founder & Lead Researcher",
        "sameAs": [
          "https://x.com/bodyhackguide",
          "https://reddit.com/r/BodyHackGuide",
          "https://reddit.com/r/BrainHackGuide",
          "https://reddit.com/r/Biohackingher"
        ],
        "worksFor": {
          "@type": "Organization",
          "name": "BodyHackGuide",
          "url": "https://www.bodyhackguide.co"
        }
      },
      "publisher": {
        "@type": "Organization",
        "name": "BodyHackGuide",
        "url": "https://www.bodyhackguide.co"
      },
      "mainContentOfPage": {
        "@type": "WebPageElement",
        "cssSelector": "main"
      },
      "about": {
        "@type": "Drug",
        "name": "Vitamin B12",
        "alternateName": [
          "Cobalamin",
          "B12",
          "Methylcobalamin",
          "MeCbl",
          "Methyl-B12",
          "Hydroxocobalamin",
          "OHCbl",
          "Hydroxy-B12",
          "Cyanocobalamin",
          "CNCbl",
          "Adenosylcobalamin",
          "AdoCbl",
          "Dibencozide",
          "Coenzyme B12"
        ],
        "description": "Vitamin B12 (cobalamin) is a water-soluble cobalt-containing vitamin that serves as a coenzyme for two critical enzymes in human metabolism: methionine synthase (cytoplasmic) and L-methylmalonyl-CoA mutase (mitochondrial). It is the largest and most structurally complex vitamin, built around a corrin ring that coordinates a central cobalt atom, with different upper-axial ligands defining the four commercially available forms — methylcobalamin, adenosylcobalamin, hydroxocobalamin, and cyanocobalamin. B12 is synthesized exclusively by bacteria and archaea; humans obtain it almost entirely from animal products (meat, fish, eggs, dairy) because plants do not produce or reliably retain bioactive cobalamin. This evolutionary dependency means that strict vegan and vegetarian diets predictably cause deficiency unless supplemented, and it means that any condition disrupting the remarkably complex absorptive pathway — atrophic gastritis, pernicious anemia, gastric bypass, ileal resection, metformin use, or proton pump inhibitor therapy — creates clinical deficiency even in people eating an omnivorous diet. Functionally, vitamin B12 sits at the intersection of methylation, DNA synthesis, hematopoiesis, myelin maintenance, and fatty acid metabolism. Methylcobalamin donates a methyl group to methionine synthase, which remethylates homocysteine to methionine and simultaneously converts 5-methyltetrahydrofolate back to tetrahydrofolate — a reaction that prevents the \"folate trap\" and keeps single-carbon units flowing through the folate cycle for purine, thymidylate, and methyl-donor synthesis. The methionine produced feeds S-adenosylmethionine (SAMe), the universal methyl donor used by dozens of methyltransferases that methylate DNA (affecting gene expression), histones (affecting chromatin state), neurotransmitters (epinephrine from norepinephrine via PNMT), myelin basic protein (affecting nerve sheath integrity), phospholipids (phosphatidylcholine via PEMT), and countless other substrates. Adenosylcobalamin serves L-methylmalonyl-CoA mutase inside mitochondria, catalyzing the isomerization of methylmalonyl-CoA to succinyl-CoA, which enters the citric acid cycle. Without adenosyl-B12, methylmalonic acid accumulates, disrupting odd-chain fatty acid metabolism and contributing to the neurological damage characteristic of B12 deficiency. Classical B12 deficiency produces a distinctive clinical picture that has been recognized for more than a century: megaloblastic anemia with large, immature red blood cells reflecting disrupted DNA synthesis in bone marrow; glossitis with a smooth, beefy-red tongue; gastrointestinal symptoms; and — most concerning — progressive neurological dysfunction known as subacute combined degeneration of the spinal cord. The neurological picture includes symmetric paresthesias (classically starting in the feet), impaired proprioception and vibratory sense, gait ataxia, weakness, optic neuropathy, and in advanced cases cognitive impairment, psychiatric symptoms, and frank dementia. The critical lesson from historical case series is that neurological damage can occur without anemia — and can become irreversible if deficiency is prolonged. Folic acid supplementation can mask the hematological changes while neurological deterioration continues, which is why high-dose folic acid in fortified foods and supplements has generated ongoing concern about missed B12 diagnoses in the elderly. For BodyHackGuide readers, the practical reality of B12 is that deficiency and insufficiency are far more common than most people realize. The classic at-risk groups — elderly with atrophic gastritis, vegans and long-term vegetarians, patients on metformin, patients on chronic PPIs, post-bariatric-surgery patients — together comprise a substantial fraction of adults. Serum B12 testing is insensitive and misses subclinical deficiency; methylmalonic acid (MMA) and homocysteine are more reliable functional markers, and holotranscobalamin (active B12) is superior where available. Oral supplementation at 500-1000 mcg/day is generally sufficient even for people lacking intrinsic factor, because passive diffusion absorbs roughly 1-2% of any oral dose regardless of the active receptor-mediated pathway. For active deficiency, parenteral hydroxocobalamin (1000 mcg IM weekly, then monthly) remains the standard and is genuinely life-changing for people with pernicious anemia or severe malabsorption. This page examines the cobalamin forms (and the overhyped claims around MTHFR and methyl-B12), absorption pathophysiology, testing, the homocysteine-lowering trials (VITACOG, VITATOPS, B-PROOF, VITAL), and practical dosing — with explicit attention to the elderly and vegan populations where B12 has the largest quality-of-life impact.",
        "activeIngredient": "Vitamin B12",
        "mechanismOfAction": "Vitamin B12 exerts all of its biological effects through two cobalamin-dependent enzymes in human cells: cytoplasmic methionine synthase (MTR, using methylcobalamin) and mitochondrial L-methylmalonyl-CoA mutase (MUT, using 5'-deoxyadenosylcobalamin). Every clinical consequence of B12 deficiency — megaloblastic anemia, subacute combined degeneration of the spinal cord, elevated homocysteine, elevated methylmalonic acid, neuropsychiatric symptoms — traces back to dysfunction of one or both of these reactions. Understanding this molecular architecture is what makes B12 pharmacology coherent. METHIONINE SYNTHASE AND THE METHYL-B12 CYCLE. Methionine synthase catalyzes the transfer of a methyl group from 5-methyltetrahydrofolate (5-MTHF) to homocysteine, regenerating methionine and releasing tetrahydrofolate (THF). This single reaction accomplishes three critical things simultaneously. First, it clears homocysteine, a sulfur-containing amino acid that is cytotoxic at elevated concentrations and is associated with cardiovascular disease, cognitive decline, and neural tube defects. Second, it produces methionine, which is activated to S-adenosylmethionine (SAMe) — the universal methyl donor used by more than 100 known human methyltransferases to methylate DNA, RNA, histones, phospholipids (phosphatidylethanolamine → phosphatidylcholine via PEMT), neurotransmitters (norepinephrine → epinephrine via PNMT, serotonin synthesis via tryptophan hydroxylation), creatine, carnitine, myelin basic protein, and countless small molecules. Third, it regenerates free THF from 5-MTHF, which keeps one-carbon units flowing through the folate cycle toward purine and thymidylate synthesis — the \"folate trap\" concept describes what happens when B12 deficiency leaves folate stuck as 5-MTHF, unable to be recycled, which is why B12 deficiency produces hematological changes (megaloblastic anemia) indistinguishable from folate deficiency. The mechanism of methionine synthase is chemically striking: the cobalt atom of methylcobalamin cycles between the Co(I), Co(II), and Co(III) oxidation states during catalysis. The methyl group is transferred as a methyl cation, with methionine synthase reductase (MTRR) periodically reducing Co(II) back to Co(I) using S-adenosylmethionine as a methyl donor for maintenance. This complicated machinery is why methionine synthase function depends not only on B12 status but also on adequate flavin (MTRR uses FAD), folate (as 5-MTHF substrate), and appropriate MTRR activity — creating nutritional interconnections that real-world deficiency patterns reflect. METHYLMALONYL-COA MUTASE AND THE ADENOSYL-B12 CYCLE. In mitochondria, adenosylcobalamin supports L-methylmalonyl-CoA mutase, which catalyzes the rearrangement of L-methylmalonyl-CoA to succinyl-CoA. This reaction sits at the tail end of the catabolic pathway for propionyl-CoA, which is itself produced by the breakdown of odd-chain fatty acids, branched-chain amino acids (isoleucine, valine, methionine, threonine), cholesterol side chains, and thymine. Succinyl-CoA enters the citric acid cycle directly, providing energy and biosynthetic carbon. When adenosyl-B12 is deficient, methylmalonyl-CoA cannot be converted, leading to accumulation of methylmalonic acid (MMA) — the specific metabolite that serves as the gold-standard functional marker of B12 deficiency, with elevations detectable long before serum B12 falls below conventional cutoffs. MMA accumulation is thought to contribute to the neurological damage of B12 deficiency through several mechanisms: disruption of myelin synthesis (MMA is incorporated into abnormal odd-chain fatty acids that destabilize myelin membranes), mitochondrial dysfunction, and direct neurotoxicity at the high concentrations seen in inherited methylmalonic acidemias. The mechanism of methylmalonyl-CoA mutase involves radical chemistry: the Co-C bond of adenosylcobalamin homolytically cleaves to generate a 5'-deoxyadenosyl radical and Co(II), the radical abstracts a hydrogen from the substrate, carbon skeleton rearrangement occurs, and the hydrogen is returned to complete the isomerization. This is one of the few radical enzymatic mechanisms in human biology, and it is chemically impossible to accomplish without adenosylcobalamin — which is why no other vitamin can substitute for B12 in this function. ABSORPTION PATHWAY. The absorption of dietary B12 is extraordinarily complex and involves at least four binding proteins across multiple gastrointestinal compartments. Dietary B12 arrives protein-bound from animal food. In the stomach, acid and pepsin release B12 from food proteins, and salivary haptocorrin (R-binder) binds it with high affinity at low pH. In the proximal small intestine, pancreatic proteases digest haptocorrin at the now-alkaline pH, releasing B12, which is then transferred to intrinsic factor (IF) — a glycoprotein secreted by parietal cells in the gastric fundus. The B12-IF complex travels to the terminal ileum, where it binds to the cubilin-amnionless receptor complex (cubam) on enterocytes for receptor-mediated endocytosis. Inside the enterocyte, B12 is released from IF, bound to transcobalamin II (TC2), and exported to portal blood. In circulation, B12-TC2 (holotranscobalamin) is the functionally active form available for cellular uptake via the transcobalamin receptor. Total serum B12 is dominated by B12 bound to haptocorrin (which is not delivered to most tissues), which is why total serum B12 can be misleadingly normal in functional deficiency. This multi-step pathway creates multiple failure points: parietal cell destruction by autoimmune antibodies (pernicious anemia) eliminates intrinsic factor; atrophic gastritis with aging reduces acid and pepsin needed to release food-bound B12; Helicobacter pylori infection similarly impairs acid production; terminal ileal disease (Crohn's, resection, radiation enteritis) destroys the cubam receptor; metformin interferes with calcium-dependent IF-B12 binding to the cubam receptor; PPIs and H2 blockers reduce acid-mediated release from food (but do not affect synthetic supplemental B12 nearly as much); and fish tapeworm (Diphyllobothrium latum) competes for B12 in the lumen. Critically, passive diffusion across the intestinal mucosa absorbs roughly 1-2% of any oral dose regardless of IF — which means that pharmacologic oral dosing (1000-2000 mcg/day) can bypass most absorptive defects and achieve adequate repletion in most patients with pernicious anemia, a finding validated in controlled trials (PMID 15671234). FORM SELECTION. Four cobalamin forms are commercially available: methylcobalamin (methyl-B12), adenosylcobalamin (dibencozide, coenzyme B12), hydroxocobalamin (OH-B12), and cyanocobalamin. The methyl and adenosyl forms are the biologically active coenzymes used directly by the two human enzymes. Hydroxocobalamin is converted intracellularly to both active forms and is the preferred parenteral form in most of the world (it has a longer half-life than cyanocobalamin, binds tissue proteins more avidly, and is retained better, allowing less frequent dosing). Cyanocobalamin is the most stable and cheapest form; it must be intracellularly converted by cyanocobalamin reductase to the active forms, releasing trace cyanide (about 20 mcg per 1000 mcg dose, a dose 50-fold below toxic thresholds and inconsequential in anyone except the severely malnourished or those with tobacco amblyopia or Leber's hereditary optic neuropathy, where hydroxocobalamin is preferred because it can actively bind and detoxify cyanide). For oral and sublingual supplementation, the practical difference between forms is small for most users: all are converted to the active coenzymes intracellularly, and serum B12 response is comparable. The strong marketing preference for methyl-B12 (particularly among biohackers citing MTHFR polymorphisms) is not well-supported by comparative pharmacokinetic data — cyanocobalamin, methylcobalamin, and hydroxocobalamin all restore serum B12, MMA, and homocysteine to normal with appropriate dosing, and MTHFR polymorphisms affect folate metabolism, not B12 utilization. The one scenario where the form does clearly matter is severe, acute deficiency with neurological manifestations, where parenteral hydroxocobalamin achieves faster tissue repletion than oral dosing and may produce more rapid neurological recovery. Chronic maintenance of repletion is essentially form-agnostic at adequate doses. HOMOCYSTEINE AND METHYLATION CROSS-TALK. Elevated homocysteine (hyperhomocysteinemia) is the biochemical signature of combined B12, folate, and B6 deficiency, with B12 being the most common single cause in adults. Homocysteine is metabolized by two pathways: remethylation to methionine (via methionine synthase with B12/folate, or via betaine-homocysteine methyltransferase in liver using choline-derived betaine) and transsulfuration to cystathionine and then cysteine (via cystathionine β-synthase with vitamin B6). Deficient B12 impairs remethylation, elevating homocysteine and disrupting the methionine/SAMe cycle. The downstream effects include reduced SAMe-dependent methylation of DNA (potential epigenetic dysregulation), neurotransmitters (affecting mood and cognition), phospholipids (affecting membrane and myelin integrity), and the catalytic cycle of methionine synthase itself. High homocysteine is independently associated with cardiovascular disease, stroke, dementia, osteoporotic fracture, and (in early pregnancy) neural tube defects, though the trials aimed at improving these outcomes with B-vitamin supplementation have yielded mixed results.",
        "dosageForm": "vial",
        "legalStatus": "Not approved for human use — research chemical",
        "warning": "For research purposes only. Not for human consumption."
      }
    },
    {
      "@context": "https://schema.org",
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "What''s the difference between methylcobalamin and cyanocobalamin? Does it actually matter which one I take?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Methylcobalamin is a biologically active coenzyme form used directly by methionine synthase; cyanocobalamin is a stable synthetic form that must be intracellularly converted (releasing about 20 mcg of cyanide per 1000 mcg dose, which is far below any toxic threshold in normal users). For most healthy people taking oral maintenance doses, the practical difference is minimal — both correct deficiency, both normalize MMA and homocysteine, and serum B12 response is comparable (PMID 23356638). The strong marketing preference for methylcobalamin is not supported by head-to-head pharmacokinetic data in healthy users. Methylcobalamin is genuinely preferred in specific populations: Leber''s hereditary optic neuropathy, tobacco amblyopia, and users with documented conversion defects. Hydroxocobalamin is actually the best parenteral form globally (longer half-life, cyanide-binding properties), and is preferred for injections. If you feel subjectively better on methylcobalamin or have one of the specific clinical indications, use it. If cost matters and you''re otherwise healthy, cyanocobalamin is entirely adequate."
          }
        },
        {
          "@type": "Question",
          "name": "I''m on metformin — do I really need to supplement B12?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Yes, probably. The Diabetes Prevention Program Outcomes Study (PMID 26764326) demonstrated that long-term metformin (≥4 years) approximately doubles the rate of biochemical B12 deficiency (4.3% vs 2.3% on placebo), and smaller studies show metformin reduces B12 absorption by 20-30% through interference with calcium-dependent intrinsic-factor-mediated uptake in the terminal ileum. Multiple consensus guidelines now recommend periodic B12 screening in patients on chronic metformin. The practical recommendation is straightforward: if you''ve been on metformin for more than 2-4 years, take 500-1000 mcg oral B12 daily (any form is adequate), and check serum B12 plus MMA every 1-2 years. You don''t need to stop metformin — high-dose oral supplementation overcomes the absorption interference. Calcium 500-1200 mg/day has been shown to partially reverse metformin''s B12 effect (PMID 16567804), but most users don''t need specific calcium supplementation for this reason."
          }
        },
        {
          "@type": "Question",
          "name": "I''m vegan (or vegetarian) — what dose of B12 do I actually need?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Vegans are functionally guaranteed to develop B12 deficiency without supplementation — Pawlak''s meta-analysis (PMID 23356638) found 52% of vegans are deficient vs <3% of omnivores. The minimum effective supplemental dose for vegans is 500-1000 mcg oral B12 daily (any form). Long-term vegans who have been supplementing adequately and have documented normal B12, MMA, and homocysteine can step down to 1000 mcg twice weekly or 2000 mcg weekly (higher dose less frequently exploits the passive-diffusion mechanism and is adequate for maintenance). Lacto-ovo-vegetarians can often maintain with 100-500 mcg daily plus dairy and egg intake, though supplementation is still recommended for insurance. Spirulina, nori, tempeh, and fermented foods contain B12 analogs that are NOT reliably bioactive in humans — do not depend on these as your B12 source. Fortified plant milks and nutritional yeast (if fortified) can provide some B12 but are not reliable substitutes for supplementation. Pregnant vegans absolutely must supplement 500-1000 mcg daily; infants of unsupplemented vegan mothers develop severe neurological damage that may be irreversible."
          }
        },
        {
          "@type": "Question",
          "name": "How do I know if I''m actually B12 deficient? My serum B12 was normal but I feel tired and foggy.",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Serum B12 is an insensitive marker that misses a substantial fraction of functional deficiency. The more sensitive tests are methylmalonic acid (MMA) and total homocysteine — MMA above 270-400 nmol/L or homocysteine above 10-12 μmol/L suggests B12 insufficiency even with normal serum B12. Holotranscobalamin (the active B12 fraction) is the most sensitive marker where available (PMID 20978274). If you have symptoms consistent with B12 deficiency (fatigue, cognitive fog, paresthesias, mood changes, glossitis) and normal serum B12, ask for MMA and homocysteine testing. A therapeutic trial is also reasonable: take 1000 mcg methylcobalamin daily for 6-8 weeks and track symptoms. Most deficient users notice improvement within 2-4 weeks. Be aware that folic acid supplementation (from fortified foods or prenatal vitamins) can correct the macrocytic anemia of B12 deficiency while masking it, which is why testing MMA and homocysteine is important rather than relying on complete blood count alone."
          }
        },
        {
          "@type": "Question",
          "name": "Do I need B12 injections, or are pills good enough?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Oral B12 at adequate doses (1000-2000 mcg/day) is equivalent to intramuscular injections for most patients, including those with pernicious anemia (PMID 9694707). This is because passive diffusion across the intestinal mucosa absorbs approximately 1-2% of any oral dose regardless of intrinsic factor status, so a 2000 mcg oral dose delivers 20-40 mcg systemically — well above daily requirements. Injections are genuinely preferred in a few scenarios: severe acute neurological symptoms where rapid tissue repletion matters; patients with very severe malabsorption from extensive ileal resection or radiation enteritis; patients with poor medication adherence; and situations where insurance/access makes monthly IM more convenient than daily oral. Many patients with pernicious anemia do well on either approach and can switch based on preference, provided they verify continued normal MMA and homocysteine on whatever regimen they choose. The bias toward injections for pernicious anemia is partially historical — B12 pills weren''t available at adequate doses when pernicious anemia treatment protocols were established."
          }
        },
        {
          "@type": "Question",
          "name": "My homocysteine is elevated. Does B12 actually help?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Yes — B12, folate, and B6 reliably lower homocysteine by 25-30%, with B12 typically the dominant contributor in deficient older adults. However, the clinical significance depends on what you''re trying to achieve. For preventing cardiovascular events, the large homocysteine-lowering trials (HOPE-2, VISP, VITATOPS) have largely failed to show benefit in folate-replete populations — lowering homocysteine does not, on current evidence, reduce heart attack or cardiovascular death (PMID 28816361). For cognitive benefit, the VITACOG trial (PMID 20838622) showed a 30% reduction in brain atrophy and improved cognitive function in elderly patients with mild cognitive impairment and elevated homocysteine treated with high-dose B12/folate/B6 for two years. The practical synthesis: if your homocysteine is elevated, identify and correct the underlying B-vitamin deficiency (usually B12 or folate); the biochemical improvement is almost universal; the clinical benefit is strongest for early cognitive decline in deficient elderly, modest for stroke prevention, and essentially absent for heart attack prevention in already folate-replete populations. Standard dosing is B12 500-1000 mcg + folate 400-800 mcg + B6 10-25 mg daily."
          }
        },
        {
          "@type": "Question",
          "name": "Can I take too much B12?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Practically, no. The Institute of Medicine has not established an upper limit because no meaningful toxicity has been observed even at very high intakes. Doses of 10,000 mcg daily (50x the RDA) have been used in trials without adverse events. Excess B12 is cleared in urine and does not accumulate to dangerous levels. There are a few caveats: high-dose B12 (particularly injections) can precipitate or worsen acne in some users (PMID 25720358); very high doses can mask folate deficiency diagnostically if folate is also inadequate; and observational data have raised weak, inconsistent signals about potential cancer associations at extreme doses, which are not established as causal. For healthy users, doses above 2000 mcg/day offer no additional benefit over 1000-2000 mcg and are mostly a waste of money. Staying in the 500-2000 mcg daily range is safe, effective, and economical for nearly all purposes."
          }
        },
        {
          "@type": "Question",
          "name": "Will B12 give me energy if I''m not deficient?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Probably not in any meaningful way. The common belief that B12 is an ''energy vitamin'' and B12 injections boost stamina in non-deficient users is largely a placebo effect. Controlled trials of B12 in non-deficient subjects consistently show no benefit on fatigue, exercise performance, or subjective energy. The apparent energy boost from B12 injections reported by some users likely reflects a combination of placebo, demand characteristics, and perhaps vitamin-injection ritual effects, rather than any physiological improvement. The scenario where B12 dramatically improves energy is correction of actual deficiency — users with low MMA/homocysteine/holotranscobalamin or symptomatic deficiency commonly describe major fatigue and cognitive improvement within 2-6 weeks of starting therapy. If you''re a healthy, well-nourished person with normal B12 status and you''re tired, B12 injections are not the answer; investigate sleep, exercise, thyroid, iron, depression, and other common causes of fatigue before concluding that B12 will help."
          }
        },
        {
          "@type": "Question",
          "name": "What about MTHFR mutations? Do I need methyl-B12 specifically?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Almost certainly not, despite extensive marketing to this effect. MTHFR polymorphisms (particularly C677T and A1298C) affect the folate cycle by reducing methylenetetrahydrofolate reductase activity, which produces modest accumulation of homocysteine and modest reduction of 5-methyltetrahydrofolate. These polymorphisms do not directly affect B12 metabolism, and there is no compelling evidence that people with MTHFR variants require methylcobalamin specifically rather than cyanocobalamin or hydroxocobalamin. MTHFR variants may modestly favor methylfolate (L-5-MTHF) over folic acid supplementation for folate repletion, but the B12 form choice is largely independent. The ''methyl-B12 for MTHFR'' recommendation is a marketing-driven pseudo-medicalization of a very common polymorphism (the heterozygous C677T occurs in 30-40% of the population) that has modest, inconsistent clinical significance. If you have MTHFR and elevated homocysteine, 500-1000 mcg of any form of B12 plus 400-800 mcg methylfolate or folic acid daily is appropriate and well-supported. If you subjectively prefer methyl-B12, there''s no harm in using it, but don''t pay a large premium for it based on MTHFR testing alone."
          }
        },
        {
          "@type": "Question",
          "name": "Is it safe to take B12 long-term? Forever?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Yes, for the overwhelming majority of users. B12 has been used as daily maintenance supplementation in pernicious anemia patients for more than 70 years, and long-term daily high-dose therapy (500-2000 mcg/day) has one of the best safety records of any supplement in clinical use. No tolerance develops, no accumulation toxicity occurs, and stopping therapy after long-term use produces no rebound phenomena. The rare issues to monitor are: acneiform skin reactions (reduce dose or switch form if they appear); allergic reactions (rare but require form changes or discontinuation); and the ongoing background concern about very-high-dose B-vitamin supplementation and cancer in specific populations (weakly supported, not a reason to avoid normal dosing). The adult over 50 population has the strongest indication for indefinite B12 supplementation given the progressive decline in food-bound B12 absorption with aging atrophic gastritis; starting 500-1000 mcg daily in your 50s and continuing indefinitely is a reasonable default. Periodic MMA and homocysteine checks every 2-5 years confirm continued adequacy; serum B12 will be elevated on supplementation and is not a useful tracking marker."
          }
        }
      ]
    },
    {
      "@context": "https://schema.org",
      "@type": "Organization",
      "@id": "https://www.bodyhackguide.co#organization",
      "name": "BodyHackGuide",
      "alternateName": "BHG",
      "url": "https://www.bodyhackguide.co",
      "logo": {
        "@type": "ImageObject",
        "url": "https://www.bodyhackguide.co/logo.png",
        "width": 512,
        "height": 512
      },
      "description": "Evidence-based research reference for peptides and nootropics. 124+ compound profiles, interactive dosing calculators, real-time vendor pricing, and trust-scored vendor reviews scored on a public, reproducible methodology applied to every vendor. BodyHackGuide and BHG Labs share common ownership, and we earn a commission on purchases through our links.",
      "foundingDate": "2024",
      "founder": {
        "@id": "https://www.bodyhackguide.co/about#person"
      },
      "sameAs": [
        "https://x.com/bodyhackguide",
        "https://reddit.com/r/BodyHackGuide",
        "https://reddit.com/r/BrainHackGuide",
        "https://reddit.com/r/Biohackingher",
        "https://discord.gg/Mhq5UdRYBA"
      ],
      "knowsAbout": [
        "Peptide research",
        "Nootropic research",
        "Biohacking",
        "Compound dosing",
        "Vendor transparency"
      ],
      "publishingPrinciples": "https://www.bodyhackguide.co/editorial-standards",
      "ethicsPolicy": "https://www.bodyhackguide.co/editorial-standards",
      "diversityPolicy": "https://www.bodyhackguide.co/editorial-standards"
    }
  ]
---

[Skip to content](#main-content)

## Research Use Only

This site is an **educational resource** for research compounds. We do **not endorse** human consumption of any compound. BodyHackGuide and **BHG Labs share common ownership**; we rank every vendor on the same public methodology, and we earn a commission on purchases through our links. By entering, you confirm you are **21 years of age or older** and agree to our [Terms](/terms) & [Privacy Policy](/privacy).

I'm 21+ — Enter SiteLeave site

   

[![BodyHackGuide](/assets/bodyhackguide-logo-DOzZNUyh.webp)BodyHackGuide ](/)

[Compare](/compare)[Wiki](/wiki)[Vendors](/vendors)[Deals](/deals)[Stacks](/stack-builder)[Nootropics](/nootropics)[Tools](/tools)

Learn

Community

Search ⌘K

[Sign In](/auth?returnTo=%2Fcompound%2Fvitamin-b12)

100K+ researchers trust BodyHackGuide — Join [r/BodyHackGuide](https://reddit.com/r/bodyhackguide) 

1.  [Home](/)
2.  [Compounds](/compare)
3.  Vitamin B12 

[Where to buy Vitamin B12](/buy/vitamin-b12) [Vitamin B12 coupon codes](/coupons/vitamin-b12) [Vitamin B12 protocol](/protocol/vitamin-b12) [Alternatives to Vitamin B12](/alternatives-to/vitamin-b12) [Vitamin B12 side effects](/side-effects/vitamin-b12)

1.  [Home](/)

3.  [Compounds](/compare)

5.  Vitamin B12 

# Vitamin B12

Foundational Preclinical 

Download  PDF

Also known as: Cobalamin, B12, Methylcobalamin, MeCbl, Methyl-B12, Hydroxocobalamin, OHCbl, Hydroxy-B12, Cyanocobalamin, CNCbl, Adenosylcobalamin, AdoCbl, Dibencozide, Coenzyme B12 

Vitamin B12 (cobalamin) is a water-soluble cobalt-containing vitamin that serves as a coenzyme for two critical enzymes in human metabolism: methionine synthase (cytoplasmic) and L-methylmalonyl-CoA mutase (mitochondrial). It is the largest and most structurally complex vitamin, built around a corrin ring that coordinates a central cobalt atom, with different upper-axial ligands defining the four commercially available forms — methylcobalamin, adenosylcobalamin, hydroxocobalamin, and cyanocobalamin.

Last reviewed: May 4, 2026 

[

Foundational

Category



](/wiki#cat-foundational)

Preclinical

Research Stage

OverviewChemical InfoDosing & ProtocolsInteractionsResearchCompare Prices1 Related

## Overview

### Best Price Available

VL

VANDL Labs

$24.99

30mL vial · vial

[Buy Now](https://www.vandl-labs.com/product/vitamin-b-12/?ref=choncho)

Coupon: `CHON`Copy

Compare 1 vendor

### At A Glance

Mechanism 

Vitamin B12 exerts all of its biological effects through two cobalamin-dependent enzymes in human cells: cytoplasmic methionine synthase (MTR, using methylcobalamin) and mitochondrial L-methylmalonyl-CoA mutase (MUT, using 5'-deoxyadenosylcobalamin). Every clinical consequence of… 

### Overview

Vitamin B12 (cobalamin) is a water-soluble cobalt-containing vitamin that serves as a coenzyme for two critical enzymes in human metabolism: methionine synthase (cytoplasmic) and L-methylmalonyl-CoA mutase (mitochondrial). It is the largest and most structurally complex vitamin, built around a corrin ring that coordinates a central cobalt atom, with different upper-axial ligands defining the four commercially available forms — methylcobalamin, adenosylcobalamin, hydroxocobalamin, and cyanocobalamin. B12 is synthesized exclusively by bacteria and archaea; humans obtain it almost entirely from animal products (meat, fish, eggs, dairy) because plants do not produce or reliably retain bioactive cobalamin. This evolutionary dependency means that strict vegan and vegetarian diets predictably cause deficiency unless supplemented, and it means that any condition disrupting the remarkably complex absorptive pathway — atrophic gastritis, pernicious anemia, gastric bypass, ileal resection, metformin use, or proton pump inhibitor therapy — creates clinical deficiency even in people eating an omnivorous diet. Functionally, vitamin B12 sits at the intersection of methylation, DNA synthesis, hematopoiesis, myelin maintenance, and fatty acid metabolism. Methylcobalamin donates a methyl group to methionine synthase, which remethylates homocysteine to methionine and simultaneously converts 5-methyltetrahydrofolate back to tetrahydrofolate — a reaction that prevents the "folate trap" and keeps single-carbon units flowing through the folate cycle for purine, thymidylate, and methyl-donor synthesis. The methionine produced feeds S-adenosylmethionine (SAMe), the universal methyl donor used by dozens of methyltransferases that methylate DNA (affecting gene expression), histones (affecting chromatin state), neurotransmitters (epinephrine from norepinephrine via PNMT), myelin basic protein (affecting nerve sheath integrity), phospholipids (phosphatidylcholine via PEMT), and countless other substrates. Adenosylcobalamin serves L-methylmalonyl-CoA mutase inside mitochondria, catalyzing the isomerization of methylmalonyl-CoA to succinyl-CoA, which enters the citric acid cycle. Without adenosyl-B12, methylmalonic acid accumulates, disrupting odd-chain fatty acid metabolism and contributing to the neurological damage characteristic of B12 deficiency. Classical B12 deficiency produces a distinctive clinical picture that has been recognized for more than a century: megaloblastic anemia with large, immature red blood cells reflecting disrupted DNA synthesis in bone marrow; glossitis with a smooth, beefy-red tongue; gastrointestinal symptoms; and — most concerning — progressive neurological dysfunction known as subacute combined degeneration of the spinal cord. The neurological picture includes symmetric paresthesias (classically starting in the feet), impaired proprioception and vibratory sense, gait ataxia, weakness, optic neuropathy, and in advanced cases cognitive impairment, psychiatric symptoms, and frank dementia. The critical lesson from historical case series is that neurological damage can occur without anemia — and can become irreversible if deficiency is prolonged. Folic acid supplementation can mask the hematological changes while neurological deterioration continues, which is why high-dose folic acid in fortified foods and supplements has generated ongoing concern about missed B12 diagnoses in the elderly. For BodyHackGuide readers, the practical reality of B12 is that deficiency and insufficiency are far more common than most people realize. The classic at-risk groups — elderly with atrophic gastritis, vegans and long-term vegetarians, patients on metformin, patients on chronic PPIs, post-bariatric-surgery patients — together comprise a substantial fraction of adults. Serum B12 testing is insensitive and misses subclinical deficiency; methylmalonic acid (MMA) and homocysteine are more reliable functional markers, and holotranscobalamin (active B12) is superior where available. Oral supplementation at 500-1000 mcg/day is generally sufficient even for people lacking intrinsic factor, because passive diffusion absorbs roughly 1-2% of any oral dose regardless of the active receptor-mediated pathway. For active deficiency, parenteral hydroxocobalamin (1000 mcg IM weekly, then monthly) remains the standard and is genuinely life-changing for people with pernicious anemia or severe malabsorption. This page examines the cobalamin forms (and the overhyped claims around MTHFR and methyl-B12), absorption pathophysiology, testing, the homocysteine-lowering trials (VITACOG, VITATOPS, B-PROOF, VITAL), and practical dosing — with explicit attention to the elderly and vegan populations where B12 has the largest quality-of-life impact.

## Chemical Information

IUPAC Name

Not yet available 

CAS Number

Not yet available 

Molecular Formula

Not yet available 

Molecular Mass

Not yet available 

Chemical data is being compiled for this compound.

## Dosing & Protocols

### Unlock Dosing Protocols

Free account gets you:

-   View beginner, intermediate & advanced protocols 
-   See weight-based dosing calculations 
-   Access cycle length & frequency data 

[Create free account](/auth)[Sign in](/auth)

2,800+ researchers already in

## Research

### Unlock Research Data

Free account gets you:

-   Browse PubMed study summaries 
-   See clinical trial phases & results 
-   Access mechanism of action details 

[Create free account](/auth)[Sign in](/auth)

2,800+ researchers already in

## Interactions

### Contraindications

Vitamin B12 has very few absolute contraindications — it is one of the safest vitamins to supplement — but a handful of clinical situations warrant caution, dose adjustment, or form selection.

LEBER'S HEREDITARY OPTIC NEUROPATHY (LHON). This mitochondrial genetic disorder causes progressive optic nerve damage. Cyanocobalamin is generally avoided in LHON because the cyanide released during conversion (about 20 mcg per 1000 mcg dose) may exacerbate optic nerve injury. Hydroxocobalamin is strongly preferred because it actively binds and detoxifies cyanide rather than releasing it. Users with LHON or a family history should consult genetics/neurology and use hydroxocobalamin or methylcobalamin exclusively.

TOBACCO AMBLYOPIA. Chronic heavy smokers developing visual symptoms may have cyanide accumulation from tobacco smoke combined with subclinical B12 deficiency. Cyanocobalamin is contraindicated; hydroxocobalamin is both diagnostic (rapid improvement suggests cyanide/B12 axis involvement) and therapeutic.

COBALT ALLERGY. True allergy to cobalt or cobalamin is rare but well-documented, typically as IgE-mediated reactions to injectable B12. Symptoms range from mild urticaria to anaphylaxis. Switching between cyanocobalamin, hydroxocobalamin, and methylcobalamin sometimes permits continued therapy; oral dosing produces fewer allergic reactions than injection. Anyone with a documented allergy should consult allergy/immunology before further exposure.

BENZYL ALCOHOL SENSITIVITY. Multi-dose injectable B12 preparations often contain benzyl alcohol as a preservative. Benzyl alcohol can cause local injection reactions and is associated with "gasping syndrome" in premature neonates. For benzyl alcohol-sensitive patients or neonates, use preservative-free single-dose vials.

HYPOKALEMIA RISK IN SEVERE ANEMIA REPLETION. Aggressive treatment of severe megaloblastic anemia with parenteral B12 can cause rapid cellular potassium uptake as erythroid precursors proliferate, producing transient hypokalemia. Not a contraindication but warrants electrolyte monitoring in severely anemic hospitalized patients during the first 1-2 weeks of treatment.

POLYCYTHEMIA VERA. Elevated serum B12 is a classic laboratory finding in polycythemia vera and can mask true B12 tissue deficiency. Patients with myeloproliferative disorders should be managed with hematology input and functional markers (MMA, homocysteine) rather than serum B12 alone.

METHYLMALONIC ACIDEMIA (INBORN ERRORS). Children with genetic methylmalonic acidemia require specialized management under metabolic genetics, with pharmacologic B12 doses often needed to stimulate residual enzyme activity. Routine self-management is not appropriate.

ACTIVE MALIGNANCY. Some observational data suggest potential associations between very high B12 supplementation and cancer progression, particularly for colorectal adenomas and certain lung cancers, though the data are inconsistent and likely reflect cancer-associated B12 binding proteins rather than causation. Patients with active malignancies should discuss high-dose supplementation with oncology. Normal maintenance dosing (100-1000 mcg/day) has no established cancer concern.

RENAL FAILURE. End-stage renal disease is associated with elevated homocysteine that is relatively resistant to B-vitamin supplementation; standard B12 doses remain appropriate for deficiency correction, but the expected homocysteine-lowering effect may be blunted.

NITROUS OXIDE EXPOSURE. Absolute caution — not a contraindication to B12 itself, but a major consideration for surgical planning in patients with marginal B12 status. Nitrous oxide irreversibly oxidizes the cobalt in cobalamin, inactivating methionine synthase. A single N2O anesthesia in a patient with low-normal B12 can precipitate acute neurological deterioration (subacute combined degeneration). Screen B12 status before elective N2O exposure in at-risk patients (elderly, vegans, metformin users, GI surgery history) and replete before surgery if deficient.

DRUG INTERACTIONS REQUIRING MONITORING OR DOSE ADJUSTMENT. Metformin (chronic use): reduces B12 absorption by 20-30%, typically requires 500-1000 mcg daily oral supplementation. PPIs and H2 blockers (chronic use): reduce B12 absorption modestly, particularly from food; synthetic supplemental B12 works normally. Chloramphenicol: reduces bone marrow response to B12 (interferes with erythropoiesis). Colchicine: reduces intestinal B12 absorption in high or chronic doses. Neomycin (oral): reduces B12 absorption (oral antibiotic, not typical systemic). Aminosalicylates: may reduce absorption. These are not contraindications but may require higher B12 dosing to achieve repletion.

ELEVATED SERUM B12 IN SYMPTOMATIC PATIENTS. Paradoxically elevated serum B12 in a patient with deficiency symptoms can occur with liver disease (release of stored B12), myeloproliferative disorders (elevated binding proteins), solid tumors (some secrete haptocorrin), and recent B12 supplementation. Functional deficiency can coexist despite elevated serum B12; MMA and homocysteine clarify the picture.

PREGNANCY AND LACTATION. B12 is safe and recommended during pregnancy and lactation; deficiency in either mother or breastfeeding infant has well-documented consequences including neural tube defects (with maternal deficiency) and infant failure-to-thrive with developmental delay (with breastfeeding from a deficient vegan mother without supplementation). Standard prenatal multivitamins include adequate B12; vegan pregnant women should verify they are taking at least 500 mcg/day.

PEDIATRICS. B12 deficiency in infants of vegan or B12-deficient mothers is a medical emergency producing irreversible neurological damage; pediatric workup and prompt repletion are required. Routine supplementation in healthy omnivore children is not necessary.

Research Disclaimer

This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.

Best Price 

$24.99

Best $/mg 

—

Vendors 

1

Listings 

1

vial

[Sign in for alerts ](/auth)

Form Allvial

Sort Price $/mg Vendor

Vendor

Product

Form

Qty

Price

$/mg

Coupon

![VANDL Labs logo](https://www.vandl-labs.com/wp-content/uploads/2026/04/LogoPack_Logo-03-scaled-2.png)

[VANDL Labs](/vendor/vandl-labs)

[50 ](/vendor-trust-scorecard)

🇺🇸 US 

Vitamin B-12 Injectable 30mL

vial 

30mL vial ● In Stock 

$24.99 BEST 

—

CHON

[Buy](https://www.vandl-labs.com/product/vitamin-b-12/?ref=choncho)

Get Vitamin B12 Price Drop Alerts

Set a target price and we'll notify you when any vendor drops below it. Current lowest: $24.99

[Sign in to set alerts](/auth)

### Sign in to leave a review

Reviews on BodyHackGuide are tied to verified user accounts and moderated before publishing. Sign in (free, no spam) to share your experience with Vitamin B12.

[Sign in](/auth)

Current low

$24.99

as of Apr 6, 2026

7-day low

—

no 7d data yet

30-day low

—

no 30d data yet

30-day change

— 

baseline building

Tracking since Apr 6, 2026 · 1 data point

### Vendors Selling Vitamin B12

[

![VANDL Labs logo](https://www.vandl-labs.com/wp-content/uploads/2026/04/LogoPack_Logo-03-scaled-2.png)

#### VANDL Labs

1 listing · from $24.99 





](/vendor/vandl-labs)

How we score these vendors

Every supplier above is graded 0–100 on COA verification, payment transparency, shipping, reviews, and active listings. Methodology published, no pay-to-rank.

[View Scorecard](/vendors/scorecard)

### Related Compounds

[View All](/wiki)

[

### Alpha-Lipoic Acid

Foundational Preclinical 

Alpha-lipoic acid (ALA), also known as thioctic acid or 1,2-dithiolane-3-pentanoic acid, is a sulfur-containing eight-carbon fatty acid derivative synthesized endogenously in mitochondria by lipoic acid synthase (LIAS).

Preclinical View Profile 

](/compound/alpha-lipoic-acid)[

### Coenzyme Q10

Foundational Preclinical 

Coenzyme Q10 (CoQ10), also known as ubiquinone-10, ubidecarenone, or simply "coenzyme Q," is a lipid-soluble benzoquinone compound with a 50-carbon isoprenoid side chain (decaprenyl tail) that anchors it within the inner mitochondrial membrane.

Preclinical View Profile 

](/compound/coq10)[

### Creatine

Foundational Preclinical 

Creatine is the most-researched nutritional supplement in sports science and has emerged over the past decade as a cornerstone compound in the broader longevity conversation, extending beyond its traditional ergogenic applications into cognitive performance, brain health in aging, sarcopenia prevention, bone health, and recovery from traumatic brain injury.

Preclinical View Profile 

](/compound/creatine)[

### Glycine

Foundational Preclinical 

Glycine is the simplest amino acid—a single hydrogen atom replacing the typical side chain found in other proteinogenic amino acids—yet it performs an wide range of biological functions.

Preclinical View Profile 

](/compound/glycine)[

### Magnesium

Foundational Preclinical 

Magnesium is the fourth most abundant cation in the human body and the second most abundant intracellular cation after potassium, with approximately 25 grams present in a typical adult—roughly 60% stored in bone, 27% in muscle, 6-7% in other soft tissues, and less than 1% in extracellular fluid including serum.

1 studies View Profile 

](/compound/magnesium)[

### Omega-3 Fatty Acids

Foundational Preclinical 

Omega-3 fatty acids represent one of the most thoroughly researched nutritional interventions of the past half-century, with thousands of clinical trials, dozens of major meta-analyses, regulatory approvals for specific pharmaceutical preparations, and foundational status in cardiovascular medicine, cognitive health, and inflammatory conditions.

12 studies View Profile 

](/compound/omega-3-fatty-acids)

[

View Full Dosage Guide →

Protocols, calculator & safety for Vitamin B12



](/guides/dosage/vitamin-b12)

### Related Articles

[All Posts](/blog)

[

#### Autoimmune Gastritis: Symptoms, the Low-Acid Twist, and What Actually Helps (2026)

Autoimmune gastritis causes LOW stomach acid and hides behind unexplained low iron for years. Symptoms, the antibody and gastrin blood panel, cancer surveillance, and what actually helps.

7/7/2026 ](/blog/autoimmune-gastritis-guide)

### Best Price

VL

VANDL Labs

$24.99

[Buy Now](https://www.vandl-labs.com/product/vitamin-b-12/?ref=choncho)

1 vendors · 1 listings

### Research Score

15 

0 PubMed studies

### Quality Indicators

Data Completeness

63% 

Description 

Mechanism of Action 

Chemical Data 

Dosing Protocols 

Safety Profile 

PubMed Studies 

Interactions 

Vendor Listings 

### Quick Facts

Trial Phase

Preclinical

[Full Dosage Guide](/guides/dosage/vitamin-b12)[Calculate Your Dose](/tools/reconstitution)

Research Disclaimer

This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use.

## Frequently Asked Questions

What''s the difference between methylcobalamin and cyanocobalamin? Does it actually matter which one I take?

Methylcobalamin is a biologically active coenzyme form used directly by methionine synthase; cyanocobalamin is a stable synthetic form that must be intracellularly converted (releasing about 20 mcg of cyanide per 1000 mcg dose, which is far below any toxic threshold in normal users). For most healthy people taking oral maintenance doses, the practical difference is minimal — both correct deficiency, both normalize MMA and homocysteine, and serum B12 response is comparable (PMID 23356638). The strong marketing preference for methylcobalamin is not supported by head-to-head pharmacokinetic data in healthy users. Methylcobalamin is genuinely preferred in specific populations: Leber''s hereditary optic neuropathy, tobacco amblyopia, and users with documented conversion defects. Hydroxocobalamin is actually the best parenteral form globally (longer half-life, cyanide-binding properties), and is preferred for injections. If you feel subjectively better on methylcobalamin or have one of the specific clinical indications, use it. If cost matters and you''re otherwise healthy, cyanocobalamin is entirely adequate.

I''m on metformin — do I really need to supplement B12?

Yes, probably. The Diabetes Prevention Program Outcomes Study (PMID 26764326) demonstrated that long-term metformin (≥4 years) approximately doubles the rate of biochemical B12 deficiency (4.3% vs 2.3% on placebo), and smaller studies show metformin reduces B12 absorption by 20-30% through interference with calcium-dependent intrinsic-factor-mediated uptake in the terminal ileum. Multiple consensus guidelines now recommend periodic B12 screening in patients on chronic metformin. The practical recommendation is straightforward: if you''ve been on metformin for more than 2-4 years, take 500-1000 mcg oral B12 daily (any form is adequate), and check serum B12 plus MMA every 1-2 years. You don''t need to stop metformin — high-dose oral supplementation overcomes the absorption interference. Calcium 500-1200 mg/day has been shown to partially reverse metformin''s B12 effect (PMID 16567804), but most users don''t need specific calcium supplementation for this reason.

I''m vegan (or vegetarian) — what dose of B12 do I actually need?

Vegans are functionally guaranteed to develop B12 deficiency without supplementation — Pawlak''s meta-analysis (PMID 23356638) found 52% of vegans are deficient vs <3% of omnivores. The minimum effective supplemental dose for vegans is 500-1000 mcg oral B12 daily (any form). Long-term vegans who have been supplementing adequately and have documented normal B12, MMA, and homocysteine can step down to 1000 mcg twice weekly or 2000 mcg weekly (higher dose less frequently exploits the passive-diffusion mechanism and is adequate for maintenance). Lacto-ovo-vegetarians can often maintain with 100-500 mcg daily plus dairy and egg intake, though supplementation is still recommended for insurance. Spirulina, nori, tempeh, and fermented foods contain B12 analogs that are NOT reliably bioactive in humans — do not depend on these as your B12 source. Fortified plant milks and nutritional yeast (if fortified) can provide some B12 but are not reliable substitutes for supplementation. Pregnant vegans absolutely must supplement 500-1000 mcg daily; infants of unsupplemented vegan mothers develop severe neurological damage that may be irreversible.

How do I know if I''m actually B12 deficient? My serum B12 was normal but I feel tired and foggy.

Serum B12 is an insensitive marker that misses a substantial fraction of functional deficiency. The more sensitive tests are methylmalonic acid (MMA) and total homocysteine — MMA above 270-400 nmol/L or homocysteine above 10-12 μmol/L suggests B12 insufficiency even with normal serum B12. Holotranscobalamin (the active B12 fraction) is the most sensitive marker where available (PMID 20978274). If you have symptoms consistent with B12 deficiency (fatigue, cognitive fog, paresthesias, mood changes, glossitis) and normal serum B12, ask for MMA and homocysteine testing. A therapeutic trial is also reasonable: take 1000 mcg methylcobalamin daily for 6-8 weeks and track symptoms. Most deficient users notice improvement within 2-4 weeks. Be aware that folic acid supplementation (from fortified foods or prenatal vitamins) can correct the macrocytic anemia of B12 deficiency while masking it, which is why testing MMA and homocysteine is important rather than relying on complete blood count alone.

Do I need B12 injections, or are pills good enough?

Oral B12 at adequate doses (1000-2000 mcg/day) is equivalent to intramuscular injections for most patients, including those with pernicious anemia (PMID 9694707). This is because passive diffusion across the intestinal mucosa absorbs approximately 1-2% of any oral dose regardless of intrinsic factor status, so a 2000 mcg oral dose delivers 20-40 mcg systemically — well above daily requirements. Injections are genuinely preferred in a few scenarios: severe acute neurological symptoms where rapid tissue repletion matters; patients with very severe malabsorption from extensive ileal resection or radiation enteritis; patients with poor medication adherence; and situations where insurance/access makes monthly IM more convenient than daily oral. Many patients with pernicious anemia do well on either approach and can switch based on preference, provided they verify continued normal MMA and homocysteine on whatever regimen they choose. The bias toward injections for pernicious anemia is partially historical — B12 pills weren''t available at adequate doses when pernicious anemia treatment protocols were established.

My homocysteine is elevated. Does B12 actually help?

Yes — B12, folate, and B6 reliably lower homocysteine by 25-30%, with B12 typically the dominant contributor in deficient older adults. However, the clinical significance depends on what you''re trying to achieve. For preventing cardiovascular events, the large homocysteine-lowering trials (HOPE-2, VISP, VITATOPS) have largely failed to show benefit in folate-replete populations — lowering homocysteine does not, on current evidence, reduce heart attack or cardiovascular death (PMID 28816361). For cognitive benefit, the VITACOG trial (PMID 20838622) showed a 30% reduction in brain atrophy and improved cognitive function in elderly patients with mild cognitive impairment and elevated homocysteine treated with high-dose B12/folate/B6 for two years. The practical synthesis: if your homocysteine is elevated, identify and correct the underlying B-vitamin deficiency (usually B12 or folate); the biochemical improvement is almost universal; the clinical benefit is strongest for early cognitive decline in deficient elderly, modest for stroke prevention, and essentially absent for heart attack prevention in already folate-replete populations. Standard dosing is B12 500-1000 mcg + folate 400-800 mcg + B6 10-25 mg daily.

Can I take too much B12?

Practically, no. The Institute of Medicine has not established an upper limit because no meaningful toxicity has been observed even at very high intakes. Doses of 10,000 mcg daily (50x the RDA) have been used in trials without adverse events. Excess B12 is cleared in urine and does not accumulate to dangerous levels. There are a few caveats: high-dose B12 (particularly injections) can precipitate or worsen acne in some users (PMID 25720358); very high doses can mask folate deficiency diagnostically if folate is also inadequate; and observational data have raised weak, inconsistent signals about potential cancer associations at extreme doses, which are not established as causal. For healthy users, doses above 2000 mcg/day offer no additional benefit over 1000-2000 mcg and are mostly a waste of money. Staying in the 500-2000 mcg daily range is safe, effective, and economical for nearly all purposes.

Will B12 give me energy if I''m not deficient?

Probably not in any meaningful way. The common belief that B12 is an ''energy vitamin'' and B12 injections boost stamina in non-deficient users is largely a placebo effect. Controlled trials of B12 in non-deficient subjects consistently show no benefit on fatigue, exercise performance, or subjective energy. The apparent energy boost from B12 injections reported by some users likely reflects a combination of placebo, demand characteristics, and perhaps vitamin-injection ritual effects, rather than any physiological improvement. The scenario where B12 dramatically improves energy is correction of actual deficiency — users with low MMA/homocysteine/holotranscobalamin or symptomatic deficiency commonly describe major fatigue and cognitive improvement within 2-6 weeks of starting therapy. If you''re a healthy, well-nourished person with normal B12 status and you''re tired, B12 injections are not the answer; investigate sleep, exercise, thyroid, iron, depression, and other common causes of fatigue before concluding that B12 will help.

What about MTHFR mutations? Do I need methyl-B12 specifically?

Almost certainly not, despite extensive marketing to this effect. MTHFR polymorphisms (particularly C677T and A1298C) affect the folate cycle by reducing methylenetetrahydrofolate reductase activity, which produces modest accumulation of homocysteine and modest reduction of 5-methyltetrahydrofolate. These polymorphisms do not directly affect B12 metabolism, and there is no compelling evidence that people with MTHFR variants require methylcobalamin specifically rather than cyanocobalamin or hydroxocobalamin. MTHFR variants may modestly favor methylfolate (L-5-MTHF) over folic acid supplementation for folate repletion, but the B12 form choice is largely independent. The ''methyl-B12 for MTHFR'' recommendation is a marketing-driven pseudo-medicalization of a very common polymorphism (the heterozygous C677T occurs in 30-40% of the population) that has modest, inconsistent clinical significance. If you have MTHFR and elevated homocysteine, 500-1000 mcg of any form of B12 plus 400-800 mcg methylfolate or folic acid daily is appropriate and well-supported. If you subjectively prefer methyl-B12, there''s no harm in using it, but don''t pay a large premium for it based on MTHFR testing alone.

Is it safe to take B12 long-term? Forever?

Yes, for the overwhelming majority of users. B12 has been used as daily maintenance supplementation in pernicious anemia patients for more than 70 years, and long-term daily high-dose therapy (500-2000 mcg/day) has one of the best safety records of any supplement in clinical use. No tolerance develops, no accumulation toxicity occurs, and stopping therapy after long-term use produces no rebound phenomena. The rare issues to monitor are: acneiform skin reactions (reduce dose or switch form if they appear); allergic reactions (rare but require form changes or discontinuation); and the ongoing background concern about very-high-dose B-vitamin supplementation and cancer in specific populations (weakly supported, not a reason to avoid normal dosing). The adult over 50 population has the strongest indication for indefinite B12 supplementation given the progressive decline in food-bound B12 absorption with aging atrophic gastritis; starting 500-1000 mcg daily in your 50s and continuing indefinitely is a reasonable default. Periodic MMA and homocysteine checks every 2-5 years confirm continued adequacy; serum B12 will be elevated on supplementation and is not a useful tracking marker.

## Research Tools

[

### Peptide Calculator

Reconstitution & syringe units



](/tools/reconstitution)[

### Reconstitution Guide

How to mix, step by step



](/guides/how-to-reconstitute-peptides)[

### Nasal Spray Calc

mL per actuation



](/tools/intranasal)[

### Half-Life Visualizer

Decay curves



](/tools/halflife)

## Related Compounds

[View All](/wiki)

[

### Alpha-Lipoic Acid

Foundational Preclinical 

Alpha-lipoic acid (ALA), also known as thioctic acid or 1,2-dithiolane-3-pentanoic acid, is a sulfur-containing eight-carbon fatty acid derivative synthesized endogenously in mitochondria by lipoic acid synthase (LIAS).

Preclinical View Profile 

](/compound/alpha-lipoic-acid)[

### Coenzyme Q10

Foundational Preclinical 

Coenzyme Q10 (CoQ10), also known as ubiquinone-10, ubidecarenone, or simply "coenzyme Q," is a lipid-soluble benzoquinone compound with a 50-carbon isoprenoid side chain (decaprenyl tail) that anchors it within the inner mitochondrial membrane.

Preclinical View Profile 

](/compound/coq10)[

### Creatine

Foundational Preclinical 

Creatine is the most-researched nutritional supplement in sports science and has emerged over the past decade as a cornerstone compound in the broader longevity conversation, extending beyond its traditional ergogenic applications into cognitive performance, brain health in aging, sarcopenia prevention, bone health, and recovery from traumatic brain injury.

Preclinical View Profile 

](/compound/creatine)[

### Glycine

Foundational Preclinical 

Glycine is the simplest amino acid—a single hydrogen atom replacing the typical side chain found in other proteinogenic amino acids—yet it performs an wide range of biological functions.

Preclinical View Profile 

](/compound/glycine)[

### Magnesium

Foundational Preclinical 

Magnesium is the fourth most abundant cation in the human body and the second most abundant intracellular cation after potassium, with approximately 25 grams present in a typical adult—roughly 60% stored in bone, 27% in muscle, 6-7% in other soft tissues, and less than 1% in extracellular fluid including serum.

1 studies View Profile 

](/compound/magnesium)[

### Omega-3 Fatty Acids

Foundational Preclinical 

Omega-3 fatty acids represent one of the most thoroughly researched nutritional interventions of the past half-century, with thousands of clinical trials, dozens of major meta-analyses, regulatory approvals for specific pharmaceutical preparations, and foundational status in cardiovascular medicine, cognitive health, and inflammatory conditions.

12 studies View Profile 

](/compound/omega-3-fatty-acids)

Free 2026 Peptide Cheat Sheet — 50 pages, PDF

Reconstitution math, concentration charts, half-lives, and vendor trust tiers. The reference we wish we had on day one.

[Download Free](/guides/peptide-cheat-sheet-download?utm_source=compound-vitamin-b12)

### Need bloodwork before starting?

Full hormone + metabolic panels from Anabolic Insights. Code CHONCH  for first-order discount.

[Order Bloodwork](https://anabolicinsights.ai/?ref=nwm2zjb)

![BodyHackGuide](/assets/bodyhackguide-logo-DOzZNUyh.webp)

### BodyHackGuide

Your biohacking research hub — compound pricing, brain health protocols, dosing tools, and vendor reviews.

[support@bodyhackguide.co](mailto:support@bodyhackguide.co)

[](https://discord.gg/Mhq5UdRYBA)[](https://reddit.com/r/BodyHackGuide)[](https://x.com/bodyhackguide)

Explore

#### Explore

-   [Compare prices](/compare)
-   [Research suppliers](/vendors)
-   [Deals](/deals)
-   [Coupons](/coupons)
-   [Nootropics](/nootropics)
-   [Brain health](/brain-health)
-   [Blog](/blog)
-   [Guides](/guides)

Tools

#### Tools

-   [Reconstitution](/tools/reconstitution)
-   [Dosage calculator](/tools/dosage)
-   [Half-life visualizer](/tools/halflife)
-   [COA lookup](/tools/coa)
-   [Cost calculator](/tools/cost-calculator)
-   [Stack builder](/stack-builder)
-   [All tools →](/tools)

Trust & vendors

#### Trust & vendors

-   [Vendor directory](/vendors)
-   [Trust scorecard](/vendors/scorecard)
-   [Get BHG verified](/vendors/get-vetted)
-   [Scoring methodology](/vendors/methodology)
-   [Peptide cheatsheet](/guides/peptide-cheat-sheet-download)

Company

#### Company

-   [About](/about)
-   [Affiliate disclosure](/affiliate-disclosure)
-   [Editorial standards](/editorial-standards)
-   [Creators](/creators)
-   [Coaches](/coaches)
-   [Privacy](/privacy)
-   [Terms](/terms)
-   [Full site directory →](/site-directory)

**Ownership & Affiliate Disclosure:** BodyHackGuide and BHG Labs share common ownership. We rank every vendor on the same public, reproducible [methodology](/vendors/methodology), and we earn a commission from purchases made through our links at no extra cost to you. Full details in our [affiliate disclosure](/affiliate-disclosure).

**Research Disclaimer:** All compounds listed are for laboratory and research purposes only. Not for human consumption. This site does not sell, distribute, or promote any products. Always consult a qualified healthcare professional and comply with local regulations.

© 2026 BodyHackGuide. All rights reserved. · [Terms](/terms) · [Privacy](/privacy)

hi 👋